CA2690091A1 - New disubstituted phenylpyrrolidines as modulators of cortical catecholaminergic neurotransmission - Google Patents

Info

Publication number

CA2690091A1

CA2690091A1 CA2690091A CA2690091A CA2690091A1 CA 2690091 A1 CA2690091 A1 CA 2690091A1 CA 2690091 A CA2690091 A CA 2690091A CA 2690091 A CA2690091 A CA 2690091A CA 2690091 A1 CA2690091 A1 CA 2690091A1

Authority

CA

Canada

Prior art keywords

difluorophenyl

pyrrolidin

mmol

chloro

fluorophenyl

Prior art date

2007-06-05

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Abandoned

Links

• Espacenet
• Global Dossier
• CIPO
• Discuss

• 230000001054 cortical effect Effects 0.000 title description 31
• 230000005062 synaptic transmission Effects 0.000 title description 5
• VDQQJMHXZCMNMU-UHFFFAOYSA-N 1-phenylpyrrolidine Chemical class C1CCCN1C1=CC=CC=C1 VDQQJMHXZCMNMU-UHFFFAOYSA-N 0.000 title description 2
• 230000000768 catecholaminergic effect Effects 0.000 title description 2
• 150000001875 compounds Chemical class 0.000 claims abstract description 184
• 238000011282 treatment Methods 0.000 claims abstract description 17
• 208000015114 central nervous system disease Diseases 0.000 claims abstract description 9
• 239000000203 mixture Substances 0.000 claims description 144
• 150000003839 salts Chemical class 0.000 claims description 35
• 238000000034 method Methods 0.000 claims description 25
• 201000000980 schizophrenia Diseases 0.000 claims description 20
• 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 claims description 16
• 150000001204 N-oxides Chemical class 0.000 claims description 15
• 208000019901 Anxiety disease Diseases 0.000 claims description 14
• 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 14
• 208000010877 cognitive disease Diseases 0.000 claims description 12
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 12
• 208000024891 symptom Diseases 0.000 claims description 12
• 239000003814 drug Substances 0.000 claims description 11
• LJSQUPHAOKTMIR-UHFFFAOYSA-N 3-(2,3-difluorophenyl)-1-ethylpyrrolidin-3-ol Chemical compound C1N(CC)CCC1(O)C1=CC=CC(F)=C1F LJSQUPHAOKTMIR-UHFFFAOYSA-N 0.000 claims description 10
• NCIWSEVOPAYAFW-UHFFFAOYSA-N 3-(3,4-difluorophenyl)-1-ethylpyrrolidin-3-ol Chemical compound C1N(CC)CCC1(O)C1=CC=C(F)C(F)=C1 NCIWSEVOPAYAFW-UHFFFAOYSA-N 0.000 claims description 10
• LFOPWHXMDFGBCZ-UHFFFAOYSA-N 3-(3,4-difluorophenyl)-1-propylpyrrolidin-3-ol Chemical compound C1N(CCC)CCC1(O)C1=CC=C(F)C(F)=C1 LFOPWHXMDFGBCZ-UHFFFAOYSA-N 0.000 claims description 10
• PZCIZLSHEPXHAY-UHFFFAOYSA-N 3-(3,5-difluorophenyl)-1-ethylpyrrolidin-3-ol Chemical compound C1N(CC)CCC1(O)C1=CC(F)=CC(F)=C1 PZCIZLSHEPXHAY-UHFFFAOYSA-N 0.000 claims description 10
• SJBRVYCKTOKPMU-UHFFFAOYSA-N 3-(3,5-difluorophenyl)-1-methylpyrrolidin-3-ol Chemical compound C1N(C)CCC1(O)C1=CC(F)=CC(F)=C1 SJBRVYCKTOKPMU-UHFFFAOYSA-N 0.000 claims description 10
• ZCCVFEZXNYDPFH-UHFFFAOYSA-N 3-(3,5-difluorophenyl)-1-propylpyrrolidin-3-ol Chemical compound C1N(CCC)CCC1(O)C1=CC(F)=CC(F)=C1 ZCCVFEZXNYDPFH-UHFFFAOYSA-N 0.000 claims description 10
• VUYBUSQWWQWBAX-UHFFFAOYSA-N 3-(3-chloro-2-fluorophenyl)-1-ethylpyrrolidin-3-ol Chemical compound C1N(CC)CCC1(O)C1=CC=CC(Cl)=C1F VUYBUSQWWQWBAX-UHFFFAOYSA-N 0.000 claims description 10
• ZNMYFXMWLGTUBE-UHFFFAOYSA-N 3-(3-chloro-2-fluorophenyl)-1-methylpyrrolidin-3-ol Chemical compound C1N(C)CCC1(O)C1=CC=CC(Cl)=C1F ZNMYFXMWLGTUBE-UHFFFAOYSA-N 0.000 claims description 10
• NIGZAKLAUVDBKT-UHFFFAOYSA-N 3-(3-chloro-5-fluorophenyl)-1-ethylpyrrolidin-3-ol Chemical compound C1N(CC)CCC1(O)C1=CC(F)=CC(Cl)=C1 NIGZAKLAUVDBKT-UHFFFAOYSA-N 0.000 claims description 10
• XYFCSWGDPHKZKM-UHFFFAOYSA-N 3-(3-chloro-5-fluorophenyl)-1-methylpyrrolidin-3-ol Chemical compound C1N(C)CCC1(O)C1=CC(F)=CC(Cl)=C1 XYFCSWGDPHKZKM-UHFFFAOYSA-N 0.000 claims description 9
• 241001465754 Metazoa Species 0.000 claims description 9
• 239000008194 pharmaceutical composition Substances 0.000 claims description 9
• 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 9
• NCYIYMVGKMWQLA-UHFFFAOYSA-N 3-(2,3-difluorophenyl)-1-propylpyrrolidin-3-ol Chemical compound C1N(CCC)CCC1(O)C1=CC=CC(F)=C1F NCYIYMVGKMWQLA-UHFFFAOYSA-N 0.000 claims description 8
• UEBPNMSACCRKBW-UHFFFAOYSA-N 1-butyl-3-(2,3-difluorophenyl)pyrrolidin-3-ol Chemical compound C1N(CCCC)CCC1(O)C1=CC=CC(F)=C1F UEBPNMSACCRKBW-UHFFFAOYSA-N 0.000 claims description 7
• KYLAQLWJVQYHFE-UHFFFAOYSA-N 1-butyl-3-(3,5-difluorophenyl)pyrrolidin-3-ol Chemical compound C1N(CCCC)CCC1(O)C1=CC(F)=CC(F)=C1 KYLAQLWJVQYHFE-UHFFFAOYSA-N 0.000 claims description 7
• 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims description 7
• NHQBQIQRZDBVFY-UHFFFAOYSA-N 3-(2,3-difluorophenyl)-1-(2-methylpropyl)pyrrolidin-3-ol Chemical compound C1N(CC(C)C)CCC1(O)C1=CC=CC(F)=C1F NHQBQIQRZDBVFY-UHFFFAOYSA-N 0.000 claims description 7
• XYBMKKZXZVSIEC-UHFFFAOYSA-N 3-(2,3-difluorophenyl)-1-methylpyrrolidin-3-ol Chemical compound C1N(C)CCC1(O)C1=CC=CC(F)=C1F XYBMKKZXZVSIEC-UHFFFAOYSA-N 0.000 claims description 7
• SYUUBVPTDUWJOY-UHFFFAOYSA-N 3-(3,5-difluorophenyl)-1-(2-methylpropyl)pyrrolidin-3-ol Chemical compound C1N(CC(C)C)CCC1(O)C1=CC(F)=CC(F)=C1 SYUUBVPTDUWJOY-UHFFFAOYSA-N 0.000 claims description 7
• 241000282414 Homo sapiens Species 0.000 claims description 7
• 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims description 7
• 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 7
• QDFWOUONMZLLJG-UHFFFAOYSA-N 1-(cyclopropylmethyl)-3-(2,3-difluorophenyl)pyrrolidin-3-ol Chemical compound C1C(O)(C=2C(=C(F)C=CC=2)F)CCN1CC1CC1 QDFWOUONMZLLJG-UHFFFAOYSA-N 0.000 claims description 6
• WGXFCVDUBAPUSV-UHFFFAOYSA-N 3-(2,3-difluorophenyl)-1-(2-methoxyethyl)pyrrolidin-3-ol Chemical compound C1N(CCOC)CCC1(O)C1=CC=CC(F)=C1F WGXFCVDUBAPUSV-UHFFFAOYSA-N 0.000 claims description 6
• JSQSGEOUGAKKCB-UHFFFAOYSA-N 3-(2,3-difluorophenyl)-1-(3,3,3-trifluoropropyl)pyrrolidin-3-ol Chemical compound C=1C=CC(F)=C(F)C=1C1(O)CCN(CCC(F)(F)F)C1 JSQSGEOUGAKKCB-UHFFFAOYSA-N 0.000 claims description 6
• QQMUFVZGYVONBS-UHFFFAOYSA-N 3-(2,3-difluorophenyl)-1-prop-2-enylpyrrolidin-3-ol Chemical compound C=1C=CC(F)=C(F)C=1C1(O)CCN(CC=C)C1 QQMUFVZGYVONBS-UHFFFAOYSA-N 0.000 claims description 6
• CCJZNYJTLCONPI-UHFFFAOYSA-N 3-(3,5-difluorophenyl)-1-(2-methoxyethyl)pyrrolidin-3-ol Chemical compound C1N(CCOC)CCC1(O)C1=CC(F)=CC(F)=C1 CCJZNYJTLCONPI-UHFFFAOYSA-N 0.000 claims description 6
• PYDSFTRKWFHUTI-UHFFFAOYSA-N 3-(3,5-difluorophenyl)-1-prop-2-enylpyrrolidin-3-ol Chemical compound C=1C(F)=CC(F)=CC=1C1(O)CCN(CC=C)C1 PYDSFTRKWFHUTI-UHFFFAOYSA-N 0.000 claims description 6
• 208000011688 Generalised anxiety disease Diseases 0.000 claims description 6
• 208000035475 disorder Diseases 0.000 claims description 6
• 208000029364 generalized anxiety disease Diseases 0.000 claims description 6
• PDOGFKRZZSBEGE-UHFFFAOYSA-N 3-(3,5-difluorophenyl)-3-fluoropyrrolidine Chemical compound FC1=CC(F)=CC(C2(F)CNCC2)=C1 PDOGFKRZZSBEGE-UHFFFAOYSA-N 0.000 claims description 5
• 208000028017 Psychotic disease Diseases 0.000 claims description 5
• 201000010099 disease Diseases 0.000 claims description 5
• 208000019906 panic disease Diseases 0.000 claims description 5
• USWSHXCFJJSHDE-UHFFFAOYSA-N 3-(2,3-dichlorophenyl)-1-ethylpyrrolidin-3-ol Chemical compound C1N(CC)CCC1(O)C1=CC=CC(Cl)=C1Cl USWSHXCFJJSHDE-UHFFFAOYSA-N 0.000 claims description 4
• CQRPFHDPCOFOIL-UHFFFAOYSA-N 3-(2,3-difluorophenyl)-3-fluoropyrrolidine Chemical compound FC1=CC=CC(C2(F)CNCC2)=C1F CQRPFHDPCOFOIL-UHFFFAOYSA-N 0.000 claims description 4
• NVJZWXSTCVALIX-UHFFFAOYSA-N 3-(2,4-difluorophenyl)-1-methylpyrrolidin-3-ol Chemical compound C1N(C)CCC1(O)C1=CC=C(F)C=C1F NVJZWXSTCVALIX-UHFFFAOYSA-N 0.000 claims description 4
• AYFLLPMVZQVMIM-UHFFFAOYSA-N 3-(3,4-dichlorophenyl)-1-ethylpyrrolidin-3-ol Chemical compound C1N(CC)CCC1(O)C1=CC=C(Cl)C(Cl)=C1 AYFLLPMVZQVMIM-UHFFFAOYSA-N 0.000 claims description 4
• RZPNURHRNBRHQL-UHFFFAOYSA-N 3-(3,4-difluorophenyl)-1-methylpyrrolidin-3-ol Chemical compound C1N(C)CCC1(O)C1=CC=C(F)C(F)=C1 RZPNURHRNBRHQL-UHFFFAOYSA-N 0.000 claims description 4
• ZJOAAWUEZFVQHP-UHFFFAOYSA-N 3-(3,5-dichlorophenyl)-1-ethylpyrrolidin-3-ol Chemical compound C1N(CC)CCC1(O)C1=CC(Cl)=CC(Cl)=C1 ZJOAAWUEZFVQHP-UHFFFAOYSA-N 0.000 claims description 4
• MTSVWPYXOZDKAU-UHFFFAOYSA-N 3-(3,5-dichlorophenyl)-3-fluoropyrrolidine Chemical compound C=1C(Cl)=CC(Cl)=CC=1C1(F)CCNC1 MTSVWPYXOZDKAU-UHFFFAOYSA-N 0.000 claims description 4
• VAYCSAOIQFQZJH-UHFFFAOYSA-N 3-(3,5-difluorophenyl)-3-fluoro-1-methylpyrrolidine Chemical compound C1N(C)CCC1(F)C1=CC(F)=CC(F)=C1 VAYCSAOIQFQZJH-UHFFFAOYSA-N 0.000 claims description 4
• SSWRIHFVYMUNQR-UHFFFAOYSA-N 3-(3-chloro-4-fluorophenyl)-1-ethylpyrrolidin-3-ol Chemical compound C1N(CC)CCC1(O)C1=CC=C(F)C(Cl)=C1 SSWRIHFVYMUNQR-UHFFFAOYSA-N 0.000 claims description 4
• UALDFWPLQVYDFB-UHFFFAOYSA-N 3-(3-chloro-4-fluorophenyl)-1-propylpyrrolidin-3-ol Chemical compound C1N(CCC)CCC1(O)C1=CC=C(F)C(Cl)=C1 UALDFWPLQVYDFB-UHFFFAOYSA-N 0.000 claims description 4
• DRHLAPLUKBFHAQ-UHFFFAOYSA-N 3-(3-chloro-5-fluorophenyl)-1-propylpyrrolidin-3-ol Chemical compound C1N(CCC)CCC1(O)C1=CC(F)=CC(Cl)=C1 DRHLAPLUKBFHAQ-UHFFFAOYSA-N 0.000 claims description 4
• 210000003169 central nervous system Anatomy 0.000 claims description 4
• 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 claims description 4
• 125000002541 furyl group Chemical group 0.000 claims description 4
• 229910052739 hydrogen Inorganic materials 0.000 claims description 4
• 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 4
• 125000000246 pyrimidin-2-yl group Chemical group [H]C1=NC(*)=NC([H])=C1[H] 0.000 claims description 4
• 125000000335 thiazolyl group Chemical group 0.000 claims description 4
• 125000001544 thienyl group Chemical group 0.000 claims description 4
• RAFSLGNAHYYRST-UHFFFAOYSA-N 3-(3,4-difluorophenyl)-1-propan-2-ylpyrrolidin-3-ol Chemical compound C1N(C(C)C)CCC1(O)C1=CC=C(F)C(F)=C1 RAFSLGNAHYYRST-UHFFFAOYSA-N 0.000 claims description 3
• 208000036864 Attention deficit/hyperactivity disease Diseases 0.000 claims description 3
• 206010034912 Phobia Diseases 0.000 claims description 3
• 238000004519 manufacturing process Methods 0.000 claims description 3
• 201000001716 specific phobia Diseases 0.000 claims description 3
• 208000020925 Bipolar disease Diseases 0.000 claims description 2
• 208000028698 Cognitive impairment Diseases 0.000 claims description 2
• 206010012289 Dementia Diseases 0.000 claims description 2
• 208000012239 Developmental disease Diseases 0.000 claims description 2
• 208000019022 Mood disease Diseases 0.000 claims description 2
• 208000000323 Tourette Syndrome Diseases 0.000 claims description 2
• 208000029560 autism spectrum disease Diseases 0.000 claims description 2
• 206010008129 cerebral palsy Diseases 0.000 claims description 2
• 239000003937 drug carrier Substances 0.000 claims description 2
• 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 2
• 208000019116 sleep disease Diseases 0.000 claims description 2
• 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 2
• 208000012902 Nervous system disease Diseases 0.000 claims 3
• 230000002265 prevention Effects 0.000 claims 3
• 241000124008 Mammalia Species 0.000 claims 2
• 208000017194 Affective disease Diseases 0.000 claims 1
• 208000020186 Schizophreniform disease Diseases 0.000 claims 1
• 239000003085 diluting agent Substances 0.000 claims 1
• 230000010249 dopaminergic function Effects 0.000 claims 1
• 208000015122 neurodegenerative disease Diseases 0.000 claims 1
• 208000020685 sleep-wake disease Diseases 0.000 claims 1
• VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 abstract description 124
• 229960003638 dopamine Drugs 0.000 abstract description 62
• SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 abstract description 51
• SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 abstract description 51
• 229960002748 norepinephrine Drugs 0.000 abstract description 51
• 210000003710 cerebral cortex Anatomy 0.000 abstract description 14
• 150000003943 catecholamines Chemical class 0.000 abstract description 9
• 230000002490 cerebral effect Effects 0.000 abstract description 4
• 210000005171 mammalian brain Anatomy 0.000 abstract description 4
• VXGOBKMZBNJSTA-UHFFFAOYSA-N 1-hydroxy-2-phenylpyrrolidine Chemical class ON1CCCC1C1=CC=CC=C1 VXGOBKMZBNJSTA-UHFFFAOYSA-N 0.000 abstract 1
• OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 564
• XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 294
• RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 195
• 238000002360 preparation method Methods 0.000 description 156
• WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 131
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 123
• 229940093499 ethyl acetate Drugs 0.000 description 98
• 235000019439 ethyl acetate Nutrition 0.000 description 98
• 150000001412 amines Chemical class 0.000 description 96
• QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 86
• YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 84
• 238000000746 purification Methods 0.000 description 75
• VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 72
• BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 68
• 238000003818 flash chromatography Methods 0.000 description 63
• 239000000741 silica gel Substances 0.000 description 63
• 229910002027 silica gel Inorganic materials 0.000 description 63
• CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 52
• 239000000243 solution Substances 0.000 description 52
• CFFZDZCDUFSOFZ-UHFFFAOYSA-N 3,4-Dihydroxy-phenylacetic acid Chemical compound OC(=O)CC1=CC=C(O)C(O)=C1 CFFZDZCDUFSOFZ-UHFFFAOYSA-N 0.000 description 50
• MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 48
• WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 46
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 44
• ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 43
• ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 43
• 239000012074 organic phase Substances 0.000 description 37
• WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 36
• 229910000027 potassium carbonate Inorganic materials 0.000 description 34
• 241000700159 Rattus Species 0.000 description 33
• 238000004128 high performance liquid chromatography Methods 0.000 description 33
• 238000001690 micro-dialysis Methods 0.000 description 32
• 229940076279 serotonin Drugs 0.000 description 29
• KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 28
• KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 27
• 229910000029 sodium carbonate Inorganic materials 0.000 description 26
• 239000008346 aqueous phase Substances 0.000 description 25
• 229910052757 nitrogen Inorganic materials 0.000 description 25
• YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 24
• DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 24
• FPDVWTTYQWWNRN-UHFFFAOYSA-N 3-(3,5-difluorophenyl)pyrrolidin-3-ol Chemical compound C=1C(F)=CC(F)=CC=1C1(O)CCNC1 FPDVWTTYQWWNRN-UHFFFAOYSA-N 0.000 description 23
• 239000003643 water by type Substances 0.000 description 23
• 239000007832 Na2SO4 Substances 0.000 description 22
• PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 22
• BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 22
• 229910052938 sodium sulfate Inorganic materials 0.000 description 22
• 235000011152 sodium sulphate Nutrition 0.000 description 22
• YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 22
• VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 21
• VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 21
• ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 20
• HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 description 20
• 230000000694 effects Effects 0.000 description 19
• QLHSIBWRPVFBLB-UHFFFAOYSA-N 3-(2,3-difluorophenyl)pyrrolidin-3-ol Chemical compound C=1C=CC(F)=C(F)C=1C1(O)CCNC1 QLHSIBWRPVFBLB-UHFFFAOYSA-N 0.000 description 18
• MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 18
• NHTMVDHEPJAVLT-UHFFFAOYSA-N Isooctane Chemical compound CC(C)CC(C)(C)C NHTMVDHEPJAVLT-UHFFFAOYSA-N 0.000 description 17
• 239000002253 acid Substances 0.000 description 17
• JVSWJIKNEAIKJW-UHFFFAOYSA-N dimethyl-hexane Natural products CCCCCC(C)C JVSWJIKNEAIKJW-UHFFFAOYSA-N 0.000 description 17
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 17
• -1 3-substituted-3-pyrrolidinols Chemical class 0.000 description 16
• IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 16
• 230000005540 biological transmission Effects 0.000 description 16
• AQRLNPVMDITEJU-UHFFFAOYSA-N triethylsilane Chemical compound CC[SiH](CC)CC AQRLNPVMDITEJU-UHFFFAOYSA-N 0.000 description 16
• 229940086542 triethylamine Drugs 0.000 description 15
• 210000004556 brain Anatomy 0.000 description 14
• XIOOWKGFGBAJQW-UHFFFAOYSA-N 3-(3,4-difluorophenyl)pyrrolidin-3-ol Chemical compound C=1C=C(F)C(F)=CC=1C1(O)CCNC1 XIOOWKGFGBAJQW-UHFFFAOYSA-N 0.000 description 13
• NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical class [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 13
• FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 13
• 210000001577 neostriatum Anatomy 0.000 description 13
• 239000012071 phase Substances 0.000 description 13
• RGJOLVNBABUXBZ-UHFFFAOYSA-N 1-benzyl-3-(3-chloro-2-fluorophenyl)pyrrolidin-3-ol Chemical compound C1C(O)(C=2C(=C(Cl)C=CC=2)F)CCN1CC1=CC=CC=C1 RGJOLVNBABUXBZ-UHFFFAOYSA-N 0.000 description 12
• KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
• 230000003920 cognitive function Effects 0.000 description 12
• RONZAEMNMFQXRA-UHFFFAOYSA-N mirtazapine Chemical compound C1C2=CC=CN=C2N2CCN(C)CC2C2=CC=CC=C21 RONZAEMNMFQXRA-UHFFFAOYSA-N 0.000 description 12
• JSOMVCDXPUXKIC-UHFFFAOYSA-N tert-butyl 3-oxopyrrolidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCC(=O)C1 JSOMVCDXPUXKIC-UHFFFAOYSA-N 0.000 description 12
• JZCBEVKAQFVMLO-UHFFFAOYSA-N 1-benzyl-3-(3,5-difluorophenyl)pyrrolidin-3-ol Chemical compound C1C(O)(C=2C=C(F)C=C(F)C=2)CCN1CC1=CC=CC=C1 JZCBEVKAQFVMLO-UHFFFAOYSA-N 0.000 description 11
• OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 11
• 230000015572 biosynthetic process Effects 0.000 description 11
• 235000019253 formic acid Nutrition 0.000 description 11
• 229940087646 methanolamine Drugs 0.000 description 11
• DHGMDHQNUNRMIN-UHFFFAOYSA-N 1-benzylpyrrolidin-3-one Chemical compound C1C(=O)CCN1CC1=CC=CC=C1 DHGMDHQNUNRMIN-UHFFFAOYSA-N 0.000 description 10
• DUUGKQCEGZLZNO-UHFFFAOYSA-N 5-hydroxyindoleacetic acid Chemical compound C1=C(O)C=C2C(CC(=O)O)=CNC2=C1 DUUGKQCEGZLZNO-UHFFFAOYSA-N 0.000 description 10
• HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 10
• 241000069665 Crenosoma striatum Species 0.000 description 10
• CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 10
• 238000006243 chemical reaction Methods 0.000 description 10
• PVWOIHVRPOBWPI-UHFFFAOYSA-N n-propyl iodide Chemical compound CCCI PVWOIHVRPOBWPI-UHFFFAOYSA-N 0.000 description 10
• 238000003786 synthesis reaction Methods 0.000 description 10
• RITJPPMZKHZNAM-UHFFFAOYSA-N 1-benzyl-3-(2,3-difluorophenyl)pyrrolidin-3-ol Chemical compound C1C(O)(C=2C(=C(F)C=CC=2)F)CCN1CC1=CC=CC=C1 RITJPPMZKHZNAM-UHFFFAOYSA-N 0.000 description 9
• HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
• CSJLBAMHHLJAAS-UHFFFAOYSA-N diethylaminosulfur trifluoride Chemical compound CCN(CC)S(F)(F)F CSJLBAMHHLJAAS-UHFFFAOYSA-N 0.000 description 9
• 238000002474 experimental method Methods 0.000 description 9
• 239000000126 substance Substances 0.000 description 9
• 238000012360 testing method Methods 0.000 description 9
• NEWIGDPXYVMHKZ-UHFFFAOYSA-N 1-benzyl-3-(3-chloro-5-fluorophenyl)pyrrolidin-3-ol Chemical compound C1C(O)(C=2C=C(Cl)C=C(F)C=2)CCN1CC1=CC=CC=C1 NEWIGDPXYVMHKZ-UHFFFAOYSA-N 0.000 description 8
• 239000013543 active substance Substances 0.000 description 8
• 230000036506 anxiety Effects 0.000 description 8
• HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 8
• 229940079593 drug Drugs 0.000 description 8
• HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 8
• 230000000144 pharmacologic effect Effects 0.000 description 8
• 239000000523 sample Substances 0.000 description 8
• 230000002739 subcortical effect Effects 0.000 description 8
• DIVQKHQLANKJQO-UHFFFAOYSA-N 3-methoxytyramine Chemical compound COC1=CC(CCN)=CC=C1O DIVQKHQLANKJQO-UHFFFAOYSA-N 0.000 description 7
• 239000001828 Gelatine Substances 0.000 description 7
• 239000000935 antidepressant agent Substances 0.000 description 7
• 238000001514 detection method Methods 0.000 description 7
• 229920000159 gelatin Polymers 0.000 description 7
• 235000019322 gelatine Nutrition 0.000 description 7
• QRMZSPFSDQBLIX-UHFFFAOYSA-N homovanillic acid Chemical compound COC1=CC(CC(O)=O)=CC=C1O QRMZSPFSDQBLIX-UHFFFAOYSA-N 0.000 description 7
• 238000001727 in vivo Methods 0.000 description 7
• 239000000543 intermediate Substances 0.000 description 7
• 230000003287 optical effect Effects 0.000 description 7
• 239000000651 prodrug Substances 0.000 description 7
• 229940002612 prodrug Drugs 0.000 description 7
• RWRDLPDLKQPQOW-UHFFFAOYSA-N tetrahydropyrrole Substances C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 7
• CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 6
• WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 6
• GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 6
• 230000009471 action Effects 0.000 description 6
• 229940005513 antidepressants Drugs 0.000 description 6
• 239000002775 capsule Substances 0.000 description 6
• 230000000052 comparative effect Effects 0.000 description 6
• 230000007585 cortical function Effects 0.000 description 6
• 238000000835 electrochemical detection Methods 0.000 description 6
• 238000009472 formulation Methods 0.000 description 6
• 230000006870 function Effects 0.000 description 6
• 238000002347 injection Methods 0.000 description 6
• 239000007924 injection Substances 0.000 description 6
• 239000008101 lactose Substances 0.000 description 6
• 229960001785 mirtazapine Drugs 0.000 description 6
• JHHZLHWJQPUNKB-UHFFFAOYSA-N pyrrolidin-3-ol Chemical compound OC1CCNC1 JHHZLHWJQPUNKB-UHFFFAOYSA-N 0.000 description 6
• 102000005962 receptors Human genes 0.000 description 6
• 108020003175 receptors Proteins 0.000 description 6
• 229940023942 remeron Drugs 0.000 description 6
• YMAPOIXMNFUOPK-UHFFFAOYSA-N 1-benzyl-3-(3,4-difluorophenyl)pyrrolidin-3-ol Chemical compound C1C(O)(C=2C=C(F)C(F)=CC=2)CCN1CC1=CC=CC=C1 YMAPOIXMNFUOPK-UHFFFAOYSA-N 0.000 description 5
• HLVFKOKELQSXIQ-UHFFFAOYSA-N 1-bromo-2-methylpropane Chemical compound CC(C)CBr HLVFKOKELQSXIQ-UHFFFAOYSA-N 0.000 description 5
• MPPPKRYCTPRNTB-UHFFFAOYSA-N 1-bromobutane Chemical compound CCCCBr MPPPKRYCTPRNTB-UHFFFAOYSA-N 0.000 description 5
• BDPHCAFTBJLERB-UHFFFAOYSA-N 3-(3-chloro-5-fluorophenyl)pyrrolidin-3-ol Chemical compound C=1C(F)=CC(Cl)=CC=1C1(O)CCNC1 BDPHCAFTBJLERB-UHFFFAOYSA-N 0.000 description 5
• 239000003310 5-hydroxyindoleacetic acid Substances 0.000 description 5
• RVWZUOPFHTYIEO-UHFFFAOYSA-N 5-hydroxyindoleacetic acid Natural products C1=C(O)C=C2C(C(=O)O)=CNC2=C1 RVWZUOPFHTYIEO-UHFFFAOYSA-N 0.000 description 5
• 102100040999 Catechol O-methyltransferase Human genes 0.000 description 5
• 108020002739 Catechol O-methyltransferase Proteins 0.000 description 5
• 229920002261 Corn starch Polymers 0.000 description 5
• VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
• BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 5
• 150000007513 acids Chemical class 0.000 description 5
• VZTDIZULWFCMLS-UHFFFAOYSA-N ammonium formate Chemical compound [NH4+].[O-]C=O VZTDIZULWFCMLS-UHFFFAOYSA-N 0.000 description 5
• 238000000502 dialysis Methods 0.000 description 5
• MHUWZNTUIIFHAS-CLFAGFIQSA-N dioleoyl phosphatidic acid Chemical group CCCCCCCC\C=C/CCCCCCCC(=O)OCC(COP(O)(O)=O)OC(=O)CCCCCCC\C=C/CCCCCCCC MHUWZNTUIIFHAS-CLFAGFIQSA-N 0.000 description 5
• 239000000706 filtrate Substances 0.000 description 5
• 210000005153 frontal cortex Anatomy 0.000 description 5
• LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical class C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 description 5
• 229910052740 iodine Inorganic materials 0.000 description 5
• 150000002500 ions Chemical class 0.000 description 5
• 229960004502 levodopa Drugs 0.000 description 5
• 229910052943 magnesium sulfate Inorganic materials 0.000 description 5
• 235000019341 magnesium sulphate Nutrition 0.000 description 5
• 238000010992 reflux Methods 0.000 description 5
• 239000002904 solvent Substances 0.000 description 5
• 210000001519 tissue Anatomy 0.000 description 5
• CWLUFVAFWWNXJZ-UHFFFAOYSA-N 1-hydroxypyrrolidine Chemical class ON1CCCC1 CWLUFVAFWWNXJZ-UHFFFAOYSA-N 0.000 description 4
• LULAYUGMBFYYEX-UHFFFAOYSA-N 3-chlorobenzoic acid Chemical compound OC(=O)C1=CC=CC(Cl)=C1 LULAYUGMBFYYEX-UHFFFAOYSA-N 0.000 description 4
• ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 4
• CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
• KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 4
• OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 4
• BHELZAPQIKSEDF-UHFFFAOYSA-N allyl bromide Chemical compound BrCC=C BHELZAPQIKSEDF-UHFFFAOYSA-N 0.000 description 4
• 238000004458 analytical method Methods 0.000 description 4
• 239000005557 antagonist Substances 0.000 description 4
• 230000001430 anti-depressive effect Effects 0.000 description 4
• 239000012267 brine Substances 0.000 description 4
• 230000003291 dopaminomimetic effect Effects 0.000 description 4
• 230000004064 dysfunction Effects 0.000 description 4
• 239000011630 iodine Substances 0.000 description 4
• INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 4
• 239000007788 liquid Substances 0.000 description 4
• 235000019359 magnesium stearate Nutrition 0.000 description 4
• 230000007246 mechanism Effects 0.000 description 4
• 230000004060 metabolic process Effects 0.000 description 4
• 230000003647 oxidation Effects 0.000 description 4
• 238000007254 oxidation reaction Methods 0.000 description 4
• 230000010412 perfusion Effects 0.000 description 4
• 230000003389 potentiating effect Effects 0.000 description 4
• 210000002442 prefrontal cortex Anatomy 0.000 description 4
• 230000002360 prefrontal effect Effects 0.000 description 4
• 230000002441 reversible effect Effects 0.000 description 4
• 238000000926 separation method Methods 0.000 description 4
• 230000000862 serotonergic effect Effects 0.000 description 4
• HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 4
• 239000007787 solid Substances 0.000 description 4
• 239000007921 spray Substances 0.000 description 4
• 230000001225 therapeutic effect Effects 0.000 description 4
• FSEUPTSLGGJFNX-UHFFFAOYSA-N 1,2,3,4-tetrahydronaphthalen-1-ylmethanamine Chemical class C1=CC=C2C(CN)CCCC2=C1 FSEUPTSLGGJFNX-UHFFFAOYSA-N 0.000 description 3
• RKWWASUTWAFKHA-UHFFFAOYSA-N 1-bromo-2,3-difluorobenzene Chemical compound FC1=CC=CC(Br)=C1F RKWWASUTWAFKHA-UHFFFAOYSA-N 0.000 description 3
• YZUPZGFPHUVJKC-UHFFFAOYSA-N 1-bromo-2-methoxyethane Chemical compound COCCBr YZUPZGFPHUVJKC-UHFFFAOYSA-N 0.000 description 3
• JHLKSIOJYMGSMB-UHFFFAOYSA-N 1-bromo-3,5-difluorobenzene Chemical compound FC1=CC(F)=CC(Br)=C1 JHLKSIOJYMGSMB-UHFFFAOYSA-N 0.000 description 3
• DRNWNTAANHEQMK-UHFFFAOYSA-N 1-bromo-3-chloro-2-fluorobenzene Chemical compound FC1=C(Cl)C=CC=C1Br DRNWNTAANHEQMK-UHFFFAOYSA-N 0.000 description 3
• GGMDFPMASIXEIR-UHFFFAOYSA-N 1-bromo-3-chloro-5-fluorobenzene Chemical compound FC1=CC(Cl)=CC(Br)=C1 GGMDFPMASIXEIR-UHFFFAOYSA-N 0.000 description 3
• KAESVJOAVNADME-UHFFFAOYSA-N 1H-pyrrole Natural products C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 3
• OIDNHAMLAAHURI-UHFFFAOYSA-N 3-(3-chloro-2-fluorophenyl)pyrrolidin-3-ol Chemical compound C=1C=CC(Cl)=C(F)C=1C1(O)CCNC1 OIDNHAMLAAHURI-UHFFFAOYSA-N 0.000 description 3
• NMIADCZEHZUXAC-UHFFFAOYSA-N 3-(3-chloro-4-fluorophenyl)pyrrolidin-3-ol Chemical compound C=1C=C(F)C(Cl)=CC=1C1(O)CCNC1 NMIADCZEHZUXAC-UHFFFAOYSA-N 0.000 description 3
• PRRFFTYUBPGHLE-UHFFFAOYSA-N 3-phenylpyrrolidine Chemical class C1NCCC1C1=CC=CC=C1 PRRFFTYUBPGHLE-UHFFFAOYSA-N 0.000 description 3
• YMQPKONILWWJQG-UHFFFAOYSA-N 4-bromo-1,2-difluorobenzene Chemical compound FC1=CC=C(Br)C=C1F YMQPKONILWWJQG-UHFFFAOYSA-N 0.000 description 3
• 102100022738 5-hydroxytryptamine receptor 1A Human genes 0.000 description 3
• 101710138638 5-hydroxytryptamine receptor 1A Proteins 0.000 description 3
• QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
• 102000007527 Autoreceptors Human genes 0.000 description 3
• 108010071131 Autoreceptors Proteins 0.000 description 3
• 229920002785 Croscarmellose sodium Polymers 0.000 description 3
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 3
• 235000019759 Maize starch Nutrition 0.000 description 3
• 206010028980 Neoplasm Diseases 0.000 description 3
• DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
• DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 3
• 230000001800 adrenalinergic effect Effects 0.000 description 3
• 235000019270 ammonium chloride Nutrition 0.000 description 3
• 125000003118 aryl group Chemical group 0.000 description 3
• 239000003693 atypical antipsychotic agent Substances 0.000 description 3
• 229940127236 atypical antipsychotics Drugs 0.000 description 3
• 230000000035 biogenic effect Effects 0.000 description 3
• 201000011510 cancer Diseases 0.000 description 3
• 229910052799 carbon Inorganic materials 0.000 description 3
• 230000019771 cognition Effects 0.000 description 3
• 230000001149 cognitive effect Effects 0.000 description 3
• 229960001681 croscarmellose sodium Drugs 0.000 description 3
• 235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 description 3
• 230000007812 deficiency Effects 0.000 description 3
• BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 3
• 229930195712 glutamate Natural products 0.000 description 3
• 239000003446 ligand Substances 0.000 description 3
• 239000011777 magnesium Substances 0.000 description 3
• 229910052749 magnesium Inorganic materials 0.000 description 3
• 239000002858 neurotransmitter agent Substances 0.000 description 3
• 231100000252 nontoxic Toxicity 0.000 description 3
• 230000003000 nontoxic effect Effects 0.000 description 3
• 230000037361 pathway Effects 0.000 description 3
• 239000000825 pharmaceutical preparation Substances 0.000 description 3
• 108090000623 proteins and genes Proteins 0.000 description 3
• 150000003235 pyrrolidines Chemical class 0.000 description 3
• 238000011160 research Methods 0.000 description 3
• 239000001509 sodium citrate Substances 0.000 description 3
• NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 3
• 239000000725 suspension Substances 0.000 description 3
• REMHUEYQLUVCKI-UHFFFAOYSA-N tert-butyl 3-(3,4-difluorophenyl)-3-hydroxypyrrolidine-1-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CCC1(O)C1=CC=C(F)C(F)=C1 REMHUEYQLUVCKI-UHFFFAOYSA-N 0.000 description 3
• ADUVQQBSUXATSJ-UHFFFAOYSA-N tert-butyl 3-(3,5-dichlorophenyl)-3-hydroxypyrrolidine-1-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CCC1(O)C1=CC(Cl)=CC(Cl)=C1 ADUVQQBSUXATSJ-UHFFFAOYSA-N 0.000 description 3
• TWJJZYMEBIUVJA-UHFFFAOYSA-N tert-butyl 3-(3-chloro-5-fluorophenyl)-3-hydroxypyrrolidine-1-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CCC1(O)C1=CC(F)=CC(Cl)=C1 TWJJZYMEBIUVJA-UHFFFAOYSA-N 0.000 description 3
• ULIYQAUQKZDZOX-UHFFFAOYSA-N 1,1,1-trifluoro-3-iodopropane Chemical compound FC(F)(F)CCI ULIYQAUQKZDZOX-UHFFFAOYSA-N 0.000 description 2
• MCLPXWSDSDCLKE-UHFFFAOYSA-N 1-benzyl-3-(2,3-difluorophenyl)-3-fluoropyrrolidine Chemical compound FC1=CC=CC(C2(F)CN(CC=3C=CC=CC=3)CC2)=C1F MCLPXWSDSDCLKE-UHFFFAOYSA-N 0.000 description 2
• FEPHUWWYNIDZHX-UHFFFAOYSA-N 1-benzyl-3-(3,5-difluorophenyl)-3-fluoropyrrolidine Chemical compound FC1=CC(F)=CC(C2(F)CN(CC=3C=CC=CC=3)CC2)=C1 FEPHUWWYNIDZHX-UHFFFAOYSA-N 0.000 description 2
• VVZCCXFFXQTHHK-UHFFFAOYSA-N 1-benzyl-3-thiophen-2-ylpyrrolidin-3-ol Chemical compound C1C(O)(C=2SC=CC=2)CCN1CC1=CC=CC=C1 VVZCCXFFXQTHHK-UHFFFAOYSA-N 0.000 description 2
• LDMOEFOXLIZJOW-UHFFFAOYSA-N 1-dodecanesulfonic acid Chemical compound CCCCCCCCCCCCS(O)(=O)=O LDMOEFOXLIZJOW-UHFFFAOYSA-N 0.000 description 2
• ULOQXIQUBWZVIK-UHFFFAOYSA-N 1-ethyl-4-[4-fluoro-3-(trifluoromethyl)phenyl]piperidine Chemical compound C1CN(CC)CCC1C1=CC=C(F)C(C(F)(F)F)=C1 ULOQXIQUBWZVIK-UHFFFAOYSA-N 0.000 description 2
• FWLQCCNYCDZVAE-UHFFFAOYSA-N 3-(2,3-dichlorophenyl)pyrrolidin-3-ol Chemical compound C=1C=CC(Cl)=C(Cl)C=1C1(O)CCNC1 FWLQCCNYCDZVAE-UHFFFAOYSA-N 0.000 description 2
• RDGNFKQNFFECKI-UHFFFAOYSA-N 3-(2,3-difluorophenyl)-1-oxido-1-propylpyrrolidin-1-ium-3-ol Chemical compound C1[N+](CCC)([O-])CCC1(O)C1=CC=CC(F)=C1F RDGNFKQNFFECKI-UHFFFAOYSA-N 0.000 description 2
• XTCRRRHFVOBXBZ-UHFFFAOYSA-N 3-(3,5-dichlorophenyl)pyrrolidin-3-ol Chemical compound C=1C(Cl)=CC(Cl)=CC=1C1(O)CCNC1 XTCRRRHFVOBXBZ-UHFFFAOYSA-N 0.000 description 2
• SDVLKDOEEJKGSQ-UHFFFAOYSA-N 4-[4-chloro-3-(trifluoromethyl)phenyl]-1-propylpiperidine Chemical compound C1CN(CCC)CCC1C1=CC=C(Cl)C(C(F)(F)F)=C1 SDVLKDOEEJKGSQ-UHFFFAOYSA-N 0.000 description 2
• QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
• GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
• 229920000945 Amylopectin Polymers 0.000 description 2
• 206010002091 Anaesthesia Diseases 0.000 description 2
• HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
• FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
• FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
• FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
• 241000282412 Homo Species 0.000 description 2
• MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
• DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
• JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 2
• 229930195725 Mannitol Natural products 0.000 description 2
• KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 2
• 239000002202 Polyethylene glycol Substances 0.000 description 2
• UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
• 229920002472 Starch Polymers 0.000 description 2
• 229930006000 Sucrose Natural products 0.000 description 2
• CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
• GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
• 230000005856 abnormality Effects 0.000 description 2
• 238000009825 accumulation Methods 0.000 description 2
• 239000000674 adrenergic antagonist Substances 0.000 description 2
• 239000000443 aerosol Substances 0.000 description 2
• 150000001408 amides Chemical class 0.000 description 2
• 230000037005 anaesthesia Effects 0.000 description 2
• 238000010171 animal model Methods 0.000 description 2
• 230000000561 anti-psychotic effect Effects 0.000 description 2
• 230000001174 ascending effect Effects 0.000 description 2
• 235000010323 ascorbic acid Nutrition 0.000 description 2
• 239000011668 ascorbic acid Substances 0.000 description 2
• 125000004429 atom Chemical group 0.000 description 2
• 230000003935 attention Effects 0.000 description 2
• 208000015802 attention deficit-hyperactivity disease Diseases 0.000 description 2
• 239000002585 base Substances 0.000 description 2
• 230000006399 behavior Effects 0.000 description 2
• 230000009286 beneficial effect Effects 0.000 description 2
• 230000037396 body weight Effects 0.000 description 2
• 210000005013 brain tissue Anatomy 0.000 description 2
• AEILLAXRDHDKDY-UHFFFAOYSA-N bromomethylcyclopropane Chemical compound BrCC1CC1 AEILLAXRDHDKDY-UHFFFAOYSA-N 0.000 description 2
• 239000001569 carbon dioxide Substances 0.000 description 2
• 229910002092 carbon dioxide Inorganic materials 0.000 description 2
• 235000011089 carbon dioxide Nutrition 0.000 description 2
• 125000002091 cationic group Chemical group 0.000 description 2
• 239000001913 cellulose Substances 0.000 description 2
• 229920002678 cellulose Polymers 0.000 description 2
• 239000003153 chemical reaction reagent Substances 0.000 description 2
• 238000013375 chromatographic separation Methods 0.000 description 2
• 238000004587 chromatography analysis Methods 0.000 description 2
• 230000007278 cognition impairment Effects 0.000 description 2
• 230000003931 cognitive performance Effects 0.000 description 2
• 238000013270 controlled release Methods 0.000 description 2
• 230000001276 controlling effect Effects 0.000 description 2
• 239000008120 corn starch Substances 0.000 description 2
• 230000000875 corresponding effect Effects 0.000 description 2
• 230000007588 cortical circuitry Effects 0.000 description 2
• 238000010511 deprotection reaction Methods 0.000 description 2
• 235000013681 dietary sucrose Nutrition 0.000 description 2
• 239000003210 dopamine receptor blocking agent Substances 0.000 description 2
• 210000001029 dorsal striatum Anatomy 0.000 description 2
• 230000008482 dysregulation Effects 0.000 description 2
• FCZCIXQGZOUIDN-UHFFFAOYSA-N ethyl 2-diethoxyphosphinothioyloxyacetate Chemical compound CCOC(=O)COP(=S)(OCC)OCC FCZCIXQGZOUIDN-UHFFFAOYSA-N 0.000 description 2
• 238000011156 evaluation Methods 0.000 description 2
• 235000013305 food Nutrition 0.000 description 2
• 239000012458 free base Substances 0.000 description 2
• 229910021397 glassy carbon Inorganic materials 0.000 description 2
• 229960003878 haloperidol Drugs 0.000 description 2
• 238000003384 imaging method Methods 0.000 description 2
• 230000005764 inhibitory process Effects 0.000 description 2
• 238000007689 inspection Methods 0.000 description 2
• KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
• 230000004807 localization Effects 0.000 description 2
• 239000000594 mannitol Substances 0.000 description 2
• 235000010355 mannitol Nutrition 0.000 description 2
• 239000012528 membrane Substances 0.000 description 2
• 230000015654 memory Effects 0.000 description 2
• 239000002207 metabolite Substances 0.000 description 2
• VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
• 150000007522 mineralic acids Chemical class 0.000 description 2
• 230000035772 mutation Effects 0.000 description 2
• 230000001537 neural effect Effects 0.000 description 2
• 210000002569 neuron Anatomy 0.000 description 2
• 230000003557 neuropsychological effect Effects 0.000 description 2
• 230000002474 noradrenergic effect Effects 0.000 description 2
• 238000010606 normalization Methods 0.000 description 2
• 210000001009 nucleus accumben Anatomy 0.000 description 2
• 150000007524 organic acids Chemical class 0.000 description 2
• 239000003960 organic solvent Substances 0.000 description 2
• 239000007800 oxidant agent Substances 0.000 description 2
• WRUUGTRCQOWXEG-UHFFFAOYSA-N pamidronate Chemical compound NCCC(O)(P(O)(O)=O)P(O)(O)=O WRUUGTRCQOWXEG-UHFFFAOYSA-N 0.000 description 2
• 239000000546 pharmaceutical excipient Substances 0.000 description 2
• 238000005191 phase separation Methods 0.000 description 2
• 150000003053 piperidines Chemical class 0.000 description 2
• 229920001223 polyethylene glycol Polymers 0.000 description 2
• 229920001592 potato starch Polymers 0.000 description 2
• 239000000843 powder Substances 0.000 description 2
• BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
• 239000002464 receptor antagonist Substances 0.000 description 2
• 229940044551 receptor antagonist Drugs 0.000 description 2
• 230000001105 regulatory effect Effects 0.000 description 2
• 229920006395 saturated elastomer Polymers 0.000 description 2
• 239000002002 slurry Substances 0.000 description 2
• 239000011734 sodium Substances 0.000 description 2
• 229910052708 sodium Inorganic materials 0.000 description 2
• 239000000600 sorbitol Substances 0.000 description 2
• 235000010356 sorbitol Nutrition 0.000 description 2
• 238000013222 sprague-dawley male rat Methods 0.000 description 2
• 239000003381 stabilizer Substances 0.000 description 2
• 238000010561 standard procedure Methods 0.000 description 2
• 235000019698 starch Nutrition 0.000 description 2
• 239000007858 starting material Substances 0.000 description 2
• 230000000638 stimulation Effects 0.000 description 2
• 229960004793 sucrose Drugs 0.000 description 2
• 235000000346 sugar Nutrition 0.000 description 2
• 238000001356 surgical procedure Methods 0.000 description 2
• DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 2
• RCJBDIGLBIGMHE-UHFFFAOYSA-N tert-butyl 3-(2,3-dichlorophenyl)-3-hydroxypyrrolidine-1-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CCC1(O)C1=CC=CC(Cl)=C1Cl RCJBDIGLBIGMHE-UHFFFAOYSA-N 0.000 description 2
• VJEOZRPVJVYKCW-UHFFFAOYSA-N tert-butyl 3-(2,3-difluorophenyl)-3-hydroxypyrrolidine-1-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CCC1(O)C1=CC=CC(F)=C1F VJEOZRPVJVYKCW-UHFFFAOYSA-N 0.000 description 2
• XHYCITONDXQLBE-UHFFFAOYSA-N tert-butyl 3-(3,4-dichlorophenyl)-3-hydroxypyrrolidine-1-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CCC1(O)C1=CC=C(Cl)C(Cl)=C1 XHYCITONDXQLBE-UHFFFAOYSA-N 0.000 description 2
• SQEUWTITUBCZDK-UHFFFAOYSA-N tert-butyl 3-(3,5-dichlorophenyl)-3-fluoropyrrolidine-1-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CCC1(F)C1=CC(Cl)=CC(Cl)=C1 SQEUWTITUBCZDK-UHFFFAOYSA-N 0.000 description 2
• XSMBDKUAAUFFOA-UHFFFAOYSA-N tert-butyl 3-(3,5-difluorophenyl)-3-hydroxypyrrolidine-1-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CCC1(O)C1=CC(F)=CC(F)=C1 XSMBDKUAAUFFOA-UHFFFAOYSA-N 0.000 description 2
• 238000003325 tomography Methods 0.000 description 2
• VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
• 235000015112 vegetable and seed oil Nutrition 0.000 description 2
• 239000008158 vegetable oil Substances 0.000 description 2
• 239000002699 waste material Substances 0.000 description 2
• 238000005303 weighing Methods 0.000 description 2
• XRASPMIURGNCCH-UHFFFAOYSA-N zoledronic acid Chemical compound OP(=O)(O)C(P(O)(O)=O)(O)CN1C=CN=C1 XRASPMIURGNCCH-UHFFFAOYSA-N 0.000 description 2
• SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical class CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
• KPWKPGFLZGMMFX-VHSXEESVSA-N (-)-camphanic acid Chemical compound C1C[C@]2(C(O)=O)OC(=O)[C@@]1(C)C2(C)C KPWKPGFLZGMMFX-VHSXEESVSA-N 0.000 description 1
• KPWKPGFLZGMMFX-ZJUUUORDSA-N (1s,4r)-1,7,7-trimethyl-2-oxo-3-oxabicyclo[2.2.1]heptane-4-carboxylic acid Chemical compound C1C[C@@]2(C(O)=O)OC(=O)[C@]1(C)C2(C)C KPWKPGFLZGMMFX-ZJUUUORDSA-N 0.000 description 1
• YONLFQNRGZXBBF-ZIAGYGMSSA-N (2r,3r)-2,3-dibenzoyloxybutanedioic acid Chemical compound O([C@@H](C(=O)O)[C@@H](OC(=O)C=1C=CC=CC=1)C(O)=O)C(=O)C1=CC=CC=C1 YONLFQNRGZXBBF-ZIAGYGMSSA-N 0.000 description 1
• NAWXUBYGYWOOIX-SFHVURJKSA-N (2s)-2-[[4-[2-(2,4-diaminoquinazolin-6-yl)ethyl]benzoyl]amino]-4-methylidenepentanedioic acid Chemical compound C1=CC2=NC(N)=NC(N)=C2C=C1CCC1=CC=C(C(=O)N[C@@H](CC(=C)C(O)=O)C(O)=O)C=C1 NAWXUBYGYWOOIX-SFHVURJKSA-N 0.000 description 1
• MPDDTAJMJCESGV-CTUHWIOQSA-M (3r,5r)-7-[2-(4-fluorophenyl)-5-[methyl-[(1r)-1-phenylethyl]carbamoyl]-4-propan-2-ylpyrazol-3-yl]-3,5-dihydroxyheptanoate Chemical compound C1([C@@H](C)N(C)C(=O)C2=NN(C(CC[C@@H](O)C[C@@H](O)CC([O-])=O)=C2C(C)C)C=2C=CC(F)=CC=2)=CC=CC=C1 MPDDTAJMJCESGV-CTUHWIOQSA-M 0.000 description 1
• WSWCOQWTEOXDQX-MQQKCMAXSA-M (E,E)-sorbate Chemical compound C\C=C\C=C\C([O-])=O WSWCOQWTEOXDQX-MQQKCMAXSA-M 0.000 description 1
• KWTSXDURSIMDCE-QMMMGPOBSA-N (S)-amphetamine Chemical compound C[C@H](N)CC1=CC=CC=C1 KWTSXDURSIMDCE-QMMMGPOBSA-N 0.000 description 1
• APQIUTYORBAGEZ-UHFFFAOYSA-N 1,1-dibromoethane Chemical compound CC(Br)Br APQIUTYORBAGEZ-UHFFFAOYSA-N 0.000 description 1
• WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
• DDMOUSALMHHKOS-UHFFFAOYSA-N 1,2-dichloro-1,1,2,2-tetrafluoroethane Chemical compound FC(F)(Cl)C(F)(F)Cl DDMOUSALMHHKOS-UHFFFAOYSA-N 0.000 description 1
• HVKCZUVMQPUWSX-UHFFFAOYSA-N 1-bromo-2,3-dichlorobenzene Chemical compound ClC1=CC=CC(Br)=C1Cl HVKCZUVMQPUWSX-UHFFFAOYSA-N 0.000 description 1
• MGHBDQZXPCTTIH-UHFFFAOYSA-N 1-bromo-2,4-difluorobenzene Chemical compound FC1=CC=C(Br)C(F)=C1 MGHBDQZXPCTTIH-UHFFFAOYSA-N 0.000 description 1
• DZHFFMWJXJBBRG-UHFFFAOYSA-N 1-bromo-3,5-dichlorobenzene Chemical compound ClC1=CC(Cl)=CC(Br)=C1 DZHFFMWJXJBBRG-UHFFFAOYSA-N 0.000 description 1
• CGXOIMUAAMILGZ-UHFFFAOYSA-N 1-butyl-3-(2,3-dichlorophenyl)pyrrolidin-3-ol Chemical compound C1N(CCCC)CCC1(O)C1=CC=CC(Cl)=C1Cl CGXOIMUAAMILGZ-UHFFFAOYSA-N 0.000 description 1
• ZNEAZSXCTAOYNX-UHFFFAOYSA-N 1-butyl-3-(2,4-dichlorophenyl)pyrrolidin-3-ol Chemical compound C1N(CCCC)CCC1(O)C1=CC=C(Cl)C=C1Cl ZNEAZSXCTAOYNX-UHFFFAOYSA-N 0.000 description 1
• TVXMSHKQZFSYRL-UHFFFAOYSA-N 1-butyl-3-(2,4-difluorophenyl)pyrrolidin-3-ol Chemical compound C1N(CCCC)CCC1(O)C1=CC=C(F)C=C1F TVXMSHKQZFSYRL-UHFFFAOYSA-N 0.000 description 1
• TZNULJQHCIKXOY-UHFFFAOYSA-N 1-butyl-3-(2-chloro-3-fluorophenyl)pyrrolidin-3-ol Chemical compound C1N(CCCC)CCC1(O)C1=CC=CC(F)=C1Cl TZNULJQHCIKXOY-UHFFFAOYSA-N 0.000 description 1
• XOAPIOZNJPDEBG-UHFFFAOYSA-N 1-butyl-3-(2-chloro-4-fluorophenyl)pyrrolidin-3-ol Chemical compound C1N(CCCC)CCC1(O)C1=CC=C(F)C=C1Cl XOAPIOZNJPDEBG-UHFFFAOYSA-N 0.000 description 1
• GZSRRHGORYUYRL-UHFFFAOYSA-N 1-butyl-3-(3,4-dichlorophenyl)pyrrolidin-3-ol Chemical compound C1N(CCCC)CCC1(O)C1=CC=C(Cl)C(Cl)=C1 GZSRRHGORYUYRL-UHFFFAOYSA-N 0.000 description 1
• ZSBKVMWKGJALIH-UHFFFAOYSA-N 1-butyl-3-(3,4-difluorophenyl)pyrrolidin-3-ol Chemical compound C1N(CCCC)CCC1(O)C1=CC=C(F)C(F)=C1 ZSBKVMWKGJALIH-UHFFFAOYSA-N 0.000 description 1
• WDALYZAHZFRJPR-UHFFFAOYSA-N 1-butyl-3-(3-chloro-2-fluorophenyl)pyrrolidin-3-ol Chemical compound C1N(CCCC)CCC1(O)C1=CC=CC(Cl)=C1F WDALYZAHZFRJPR-UHFFFAOYSA-N 0.000 description 1
• WWWJAJAXNZNSBD-UHFFFAOYSA-N 1-butyl-3-(3-chloro-4-fluorophenyl)pyrrolidin-3-ol Chemical compound C1N(CCCC)CCC1(O)C1=CC=C(F)C(Cl)=C1 WWWJAJAXNZNSBD-UHFFFAOYSA-N 0.000 description 1
• NPHSYPAGIPCLLZ-UHFFFAOYSA-N 1-butyl-3-(3-chloro-5-fluorophenyl)pyrrolidin-3-ol Chemical compound C1N(CCCC)CCC1(O)C1=CC(F)=CC(Cl)=C1 NPHSYPAGIPCLLZ-UHFFFAOYSA-N 0.000 description 1
• PYWPCTYJACAULT-UHFFFAOYSA-N 1-butyl-3-(4-chloro-2-fluorophenyl)pyrrolidin-3-ol Chemical compound C1N(CCCC)CCC1(O)C1=CC=C(Cl)C=C1F PYWPCTYJACAULT-UHFFFAOYSA-N 0.000 description 1
• ROTMKWUETPTZJM-UHFFFAOYSA-N 1-butyl-3-(4-chloro-3-fluorophenyl)pyrrolidin-3-ol Chemical compound C1N(CCCC)CCC1(O)C1=CC=C(Cl)C(F)=C1 ROTMKWUETPTZJM-UHFFFAOYSA-N 0.000 description 1
• KVGOXGQSTGQXDD-UHFFFAOYSA-N 1-decane-sulfonic-acid Chemical compound CCCCCCCCCCS(O)(=O)=O KVGOXGQSTGQXDD-UHFFFAOYSA-N 0.000 description 1
• OTWVFHZMWFGHSJ-UHFFFAOYSA-N 1-fluoropyrrolidine Chemical class FN1CCCC1 OTWVFHZMWFGHSJ-UHFFFAOYSA-N 0.000 description 1
• LLSKXGRDUPMXLC-UHFFFAOYSA-N 1-phenylpiperidine Chemical class C1CCCCN1C1=CC=CC=C1 LLSKXGRDUPMXLC-UHFFFAOYSA-N 0.000 description 1
• KJUGUADJHNHALS-UHFFFAOYSA-N 1H-tetrazole Substances C=1N=NNN=1 KJUGUADJHNHALS-UHFFFAOYSA-N 0.000 description 1
• ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 2,3-dimethylbutane Chemical group CC(C)C(C)C ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 0.000 description 1
• AWFYPPSBLUWMFQ-UHFFFAOYSA-N 2-[5-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-1,3,4-oxadiazol-2-yl]-1-(1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1=NN=C(O1)CC(=O)N1CC2=C(CC1)NN=C2 AWFYPPSBLUWMFQ-UHFFFAOYSA-N 0.000 description 1
• NAMYKGVDVNBCFQ-UHFFFAOYSA-N 2-bromopropane Chemical compound CC(C)Br NAMYKGVDVNBCFQ-UHFFFAOYSA-N 0.000 description 1
• 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 description 1
• MLJFSCQAPVMWTF-UHFFFAOYSA-N 3-(2,3-dichlorophenyl)-1-(2-methoxyethyl)pyrrolidin-3-ol Chemical compound C1N(CCOC)CCC1(O)C1=CC=CC(Cl)=C1Cl MLJFSCQAPVMWTF-UHFFFAOYSA-N 0.000 description 1
• ISFCNDRYTZYVQM-UHFFFAOYSA-N 3-(2,3-dichlorophenyl)-1-(2-methylpropyl)pyrrolidin-3-ol Chemical compound C1N(CC(C)C)CCC1(O)C1=CC=CC(Cl)=C1Cl ISFCNDRYTZYVQM-UHFFFAOYSA-N 0.000 description 1
• UIDKLKSKYANWJV-UHFFFAOYSA-N 3-(2,3-dichlorophenyl)-1-methylpyrrolidin-3-ol Chemical compound C1N(C)CCC1(O)C1=CC=CC(Cl)=C1Cl UIDKLKSKYANWJV-UHFFFAOYSA-N 0.000 description 1
• GONXBDZZBAKBAK-UHFFFAOYSA-N 3-(2,3-dichlorophenyl)-1-propylpyrrolidin-3-ol Chemical compound C1N(CCC)CCC1(O)C1=CC=CC(Cl)=C1Cl GONXBDZZBAKBAK-UHFFFAOYSA-N 0.000 description 1
• JMNPTXHTACMWMY-UHFFFAOYSA-N 3-(2,3-dichlorophenyl)-3-fluoro-1-hydroxypyrrolidine Chemical compound C1N(O)CCC1(F)C1=CC=CC(Cl)=C1Cl JMNPTXHTACMWMY-UHFFFAOYSA-N 0.000 description 1
• YEEVVJDGKDLSFP-UHFFFAOYSA-N 3-(2,3-dichlorophenyl)-3-fluoro-1-methyl-1-oxidopyrrolidin-1-ium Chemical compound C1[N+](C)([O-])CCC1(F)C1=CC=CC(Cl)=C1Cl YEEVVJDGKDLSFP-UHFFFAOYSA-N 0.000 description 1
• CAXSSUYAAPYRJW-UHFFFAOYSA-N 3-(2,3-dichlorophenyl)-3-fluoro-1-methylpyrrolidine Chemical compound C1N(C)CCC1(F)C1=CC=CC(Cl)=C1Cl CAXSSUYAAPYRJW-UHFFFAOYSA-N 0.000 description 1
• NTWCYYWMDLXCNS-UHFFFAOYSA-N 3-(2,3-dichlorophenyl)-3-fluoropyrrolidine Chemical compound C=1C=CC(Cl)=C(Cl)C=1C1(F)CCNC1 NTWCYYWMDLXCNS-UHFFFAOYSA-N 0.000 description 1
• AJYXJSPQGJVGCZ-UHFFFAOYSA-N 3-(2,3-difluorophenyl)-3-fluoro-1-hydroxypyrrolidine Chemical compound C1N(O)CCC1(F)C1=CC=CC(F)=C1F AJYXJSPQGJVGCZ-UHFFFAOYSA-N 0.000 description 1
• LNCBXRIQKDQAQA-UHFFFAOYSA-N 3-(2,3-difluorophenyl)-3-fluoro-1-methyl-1-oxidopyrrolidin-1-ium Chemical compound C1[N+](C)([O-])CCC1(F)C1=CC=CC(F)=C1F LNCBXRIQKDQAQA-UHFFFAOYSA-N 0.000 description 1
• XVZMAGBSTUDVKQ-UHFFFAOYSA-N 3-(2,3-difluorophenyl)-3-fluoro-1-methylpyrrolidine Chemical compound C1N(C)CCC1(F)C1=CC=CC(F)=C1F XVZMAGBSTUDVKQ-UHFFFAOYSA-N 0.000 description 1
• QUMQUEKRRQLNEP-UHFFFAOYSA-N 3-(2,4-dichlorophenyl)-1-(2-methoxyethyl)pyrrolidin-3-ol Chemical compound C1N(CCOC)CCC1(O)C1=CC=C(Cl)C=C1Cl QUMQUEKRRQLNEP-UHFFFAOYSA-N 0.000 description 1
• DPKKDMIBXHOGBG-UHFFFAOYSA-N 3-(2,4-dichlorophenyl)-1-(2-methylpropyl)pyrrolidin-3-ol Chemical compound C1N(CC(C)C)CCC1(O)C1=CC=C(Cl)C=C1Cl DPKKDMIBXHOGBG-UHFFFAOYSA-N 0.000 description 1
• UGQCQENXJPUJOJ-UHFFFAOYSA-N 3-(2,4-dichlorophenyl)-1-ethylpyrrolidin-3-ol Chemical compound C1N(CC)CCC1(O)C1=CC=C(Cl)C=C1Cl UGQCQENXJPUJOJ-UHFFFAOYSA-N 0.000 description 1
• QAVMWLULEFUZOG-UHFFFAOYSA-N 3-(2,4-dichlorophenyl)-1-methylpyrrolidin-3-ol Chemical compound C1N(C)CCC1(O)C1=CC=C(Cl)C=C1Cl QAVMWLULEFUZOG-UHFFFAOYSA-N 0.000 description 1
• XTGLUPGERQSUFY-UHFFFAOYSA-N 3-(2,4-dichlorophenyl)-1-propylpyrrolidin-3-ol Chemical compound C1N(CCC)CCC1(O)C1=CC=C(Cl)C=C1Cl XTGLUPGERQSUFY-UHFFFAOYSA-N 0.000 description 1
• WAHATSDUKUIOJH-UHFFFAOYSA-N 3-(2,4-dichlorophenyl)-3-fluoro-1-hydroxypyrrolidine Chemical compound C1N(O)CCC1(F)C1=CC=C(Cl)C=C1Cl WAHATSDUKUIOJH-UHFFFAOYSA-N 0.000 description 1
• ZIEIEQQJFGNDHH-UHFFFAOYSA-N 3-(2,4-dichlorophenyl)-3-fluoro-1-methyl-1-oxidopyrrolidin-1-ium Chemical compound C1[N+](C)([O-])CCC1(F)C1=CC=C(Cl)C=C1Cl ZIEIEQQJFGNDHH-UHFFFAOYSA-N 0.000 description 1
• DBZOUENQYQQBCV-UHFFFAOYSA-N 3-(2,4-dichlorophenyl)-3-fluoro-1-methylpyrrolidine Chemical compound C1N(C)CCC1(F)C1=CC=C(Cl)C=C1Cl DBZOUENQYQQBCV-UHFFFAOYSA-N 0.000 description 1
• VFHCFDRSMQXTKH-UHFFFAOYSA-N 3-(2,4-dichlorophenyl)-3-fluoropyrrolidine Chemical compound C=1C=C(Cl)C=C(Cl)C=1C1(F)CCNC1 VFHCFDRSMQXTKH-UHFFFAOYSA-N 0.000 description 1
• DTQGVYHCSQNYFC-UHFFFAOYSA-N 3-(2,4-difluorophenyl)-1-(2-methylpropyl)pyrrolidin-3-ol Chemical compound C1N(CC(C)C)CCC1(O)C1=CC=C(F)C=C1F DTQGVYHCSQNYFC-UHFFFAOYSA-N 0.000 description 1
• ZLVVUZAAZJVPFT-UHFFFAOYSA-N 3-(2,4-difluorophenyl)-1-ethylpyrrolidin-3-ol Chemical compound C1N(CC)CCC1(O)C1=CC=C(F)C=C1F ZLVVUZAAZJVPFT-UHFFFAOYSA-N 0.000 description 1
• IEHPZORVJZFJKM-UHFFFAOYSA-N 3-(2,4-difluorophenyl)-1-propylpyrrolidin-3-ol Chemical compound C1N(CCC)CCC1(O)C1=CC=C(F)C=C1F IEHPZORVJZFJKM-UHFFFAOYSA-N 0.000 description 1
• ZLEIHMQXHXCHBD-UHFFFAOYSA-N 3-(2,4-difluorophenyl)-3-fluoro-1-hydroxypyrrolidine Chemical compound C1N(O)CCC1(F)C1=CC=C(F)C=C1F ZLEIHMQXHXCHBD-UHFFFAOYSA-N 0.000 description 1
• WLMSSFMKLSORIG-UHFFFAOYSA-N 3-(2,4-difluorophenyl)-3-fluoro-1-methyl-1-oxidopyrrolidin-1-ium Chemical compound C1[N+](C)([O-])CCC1(F)C1=CC=C(F)C=C1F WLMSSFMKLSORIG-UHFFFAOYSA-N 0.000 description 1
• ZQLBKWNGQSWNNQ-UHFFFAOYSA-N 3-(2,4-difluorophenyl)-3-fluoro-1-methylpyrrolidine Chemical compound C1N(C)CCC1(F)C1=CC=C(F)C=C1F ZQLBKWNGQSWNNQ-UHFFFAOYSA-N 0.000 description 1
• QJBHZAFJGYJTCJ-UHFFFAOYSA-N 3-(2,4-difluorophenyl)-3-fluoropyrrolidine Chemical compound FC1=CC(F)=CC=C1C1(F)CNCC1 QJBHZAFJGYJTCJ-UHFFFAOYSA-N 0.000 description 1
• ATCJSUSCWSNPBV-UHFFFAOYSA-N 3-(2-chloro-3-fluorophenyl)-1-(2-methoxyethyl)pyrrolidin-3-ol Chemical compound C1N(CCOC)CCC1(O)C1=CC=CC(F)=C1Cl ATCJSUSCWSNPBV-UHFFFAOYSA-N 0.000 description 1
• ZGXHPDWROUKBRQ-UHFFFAOYSA-N 3-(2-chloro-3-fluorophenyl)-1-(2-methylpropyl)pyrrolidin-3-ol Chemical compound C1N(CC(C)C)CCC1(O)C1=CC=CC(F)=C1Cl ZGXHPDWROUKBRQ-UHFFFAOYSA-N 0.000 description 1
• OBXOXAHANPQLEE-UHFFFAOYSA-N 3-(2-chloro-3-fluorophenyl)-1-ethylpyrrole Chemical compound ClC1=C(C=CC=C1F)C1=CN(C=C1)CC OBXOXAHANPQLEE-UHFFFAOYSA-N 0.000 description 1
• CLVKQVLQXAZRQH-UHFFFAOYSA-N 3-(2-chloro-3-fluorophenyl)-1-methylpyrrolidin-3-ol Chemical compound C1N(C)CCC1(O)C1=CC=CC(F)=C1Cl CLVKQVLQXAZRQH-UHFFFAOYSA-N 0.000 description 1
• JOJYUJIOJIBRCL-UHFFFAOYSA-N 3-(2-chloro-3-fluorophenyl)-1-propylpyrrolidin-3-ol Chemical compound C1N(CCC)CCC1(O)C1=CC=CC(F)=C1Cl JOJYUJIOJIBRCL-UHFFFAOYSA-N 0.000 description 1
• OQQROSGIQMUDHA-UHFFFAOYSA-N 3-(2-chloro-3-fluorophenyl)-3-fluoro-1-methyl-1-oxidopyrrolidin-1-ium Chemical compound C1[N+](C)([O-])CCC1(F)C1=CC=CC(F)=C1Cl OQQROSGIQMUDHA-UHFFFAOYSA-N 0.000 description 1
• HFJYSVNGEBDOSN-UHFFFAOYSA-N 3-(2-chloro-3-fluorophenyl)-3-fluoro-1-methylpyrrolidine Chemical compound C1N(C)CCC1(F)C1=CC=CC(F)=C1Cl HFJYSVNGEBDOSN-UHFFFAOYSA-N 0.000 description 1
• FRHSLFINXTZXFS-UHFFFAOYSA-N 3-(2-chloro-3-fluorophenyl)-3-fluoropyrrolidine Chemical compound FC1=CC=CC(C2(F)CNCC2)=C1Cl FRHSLFINXTZXFS-UHFFFAOYSA-N 0.000 description 1
• BDSOAXTYDXFCHJ-UHFFFAOYSA-N 3-(2-chloro-4-fluorophenyl)-1-(2-methoxyethyl)pyrrolidin-3-ol Chemical compound C1N(CCOC)CCC1(O)C1=CC=C(F)C=C1Cl BDSOAXTYDXFCHJ-UHFFFAOYSA-N 0.000 description 1
• DQEITZQRBJJWET-UHFFFAOYSA-N 3-(2-chloro-4-fluorophenyl)-1-(2-methylpropyl)pyrrolidin-3-ol Chemical compound C1N(CC(C)C)CCC1(O)C1=CC=C(F)C=C1Cl DQEITZQRBJJWET-UHFFFAOYSA-N 0.000 description 1
• HBYVGBBPETULMI-UHFFFAOYSA-N 3-(2-chloro-4-fluorophenyl)-1-ethylpyrrolidin-3-ol Chemical compound C1N(CC)CCC1(O)C1=CC=C(F)C=C1Cl HBYVGBBPETULMI-UHFFFAOYSA-N 0.000 description 1
• GFDVJXIZAOJNTE-UHFFFAOYSA-N 3-(2-chloro-4-fluorophenyl)-1-methylpyrrolidin-3-ol Chemical compound C1N(C)CCC1(O)C1=CC=C(F)C=C1Cl GFDVJXIZAOJNTE-UHFFFAOYSA-N 0.000 description 1
• XAYMYAIBOHFXOX-UHFFFAOYSA-N 3-(2-chloro-4-fluorophenyl)-1-propylpyrrolidin-3-ol Chemical compound C1N(CCC)CCC1(O)C1=CC=C(F)C=C1Cl XAYMYAIBOHFXOX-UHFFFAOYSA-N 0.000 description 1
• LPMVVCIEHOERJZ-UHFFFAOYSA-N 3-(2-chloro-4-fluorophenyl)-3-fluoro-1-methyl-1-oxidopyrrolidin-1-ium Chemical compound C1[N+](C)([O-])CCC1(F)C1=CC=C(F)C=C1Cl LPMVVCIEHOERJZ-UHFFFAOYSA-N 0.000 description 1
• SDPGJCMCGKCLFG-UHFFFAOYSA-N 3-(2-chloro-4-fluorophenyl)-3-fluoro-1-methylpyrrolidine Chemical compound C1N(C)CCC1(F)C1=CC=C(F)C=C1Cl SDPGJCMCGKCLFG-UHFFFAOYSA-N 0.000 description 1
• GBKOZIRBPLAQAI-UHFFFAOYSA-N 3-(2-chloro-4-fluorophenyl)-3-fluoropyrrole Chemical compound ClC1=C(C=CC(=C1)F)C1(C=NC=C1)F GBKOZIRBPLAQAI-UHFFFAOYSA-N 0.000 description 1
• YUFPHJGILIMOGL-UHFFFAOYSA-N 3-(2-chloro-4-fluorophenyl)-3-fluoropyrrolidine Chemical compound ClC1=CC(F)=CC=C1C1(F)CNCC1 YUFPHJGILIMOGL-UHFFFAOYSA-N 0.000 description 1
• RISUNXVJFNIVAH-UHFFFAOYSA-N 3-(3,4-dichlorophenyl)-1-(2-methoxyethyl)pyrrolidin-3-ol Chemical compound C1N(CCOC)CCC1(O)C1=CC=C(Cl)C(Cl)=C1 RISUNXVJFNIVAH-UHFFFAOYSA-N 0.000 description 1
• STFRABFEGWQELM-UHFFFAOYSA-N 3-(3,4-dichlorophenyl)-1-(2-methylpropyl)pyrrolidin-3-ol Chemical compound C1N(CC(C)C)CCC1(O)C1=CC=C(Cl)C(Cl)=C1 STFRABFEGWQELM-UHFFFAOYSA-N 0.000 description 1
• VHVGKJOIJKSRMJ-UHFFFAOYSA-N 3-(3,4-dichlorophenyl)-1-methylpyrrolidin-3-ol Chemical compound C1N(C)CCC1(O)C1=CC=C(Cl)C(Cl)=C1 VHVGKJOIJKSRMJ-UHFFFAOYSA-N 0.000 description 1
• GHPPBINGBOSLJT-UHFFFAOYSA-N 3-(3,4-dichlorophenyl)-1-propylpyrrolidin-3-ol Chemical compound C1N(CCC)CCC1(O)C1=CC=C(Cl)C(Cl)=C1 GHPPBINGBOSLJT-UHFFFAOYSA-N 0.000 description 1
• JYOTZBIFVXPYOC-UHFFFAOYSA-N 3-(3,4-dichlorophenyl)-3-fluoro-1-hydroxypyrrolidine Chemical compound C1N(O)CCC1(F)C1=CC=C(Cl)C(Cl)=C1 JYOTZBIFVXPYOC-UHFFFAOYSA-N 0.000 description 1
• MHGRAPHNDBEKDW-UHFFFAOYSA-N 3-(3,4-dichlorophenyl)-3-fluoro-1-methyl-1-oxidopyrrolidin-1-ium Chemical compound C1[N+](C)([O-])CCC1(F)C1=CC=C(Cl)C(Cl)=C1 MHGRAPHNDBEKDW-UHFFFAOYSA-N 0.000 description 1
• FJDYNCPWXAMTQM-UHFFFAOYSA-N 3-(3,4-dichlorophenyl)-3-fluoro-1-methylpyrrolidine Chemical compound C1N(C)CCC1(F)C1=CC=C(Cl)C(Cl)=C1 FJDYNCPWXAMTQM-UHFFFAOYSA-N 0.000 description 1
• XYUXXRTVBNMNBR-UHFFFAOYSA-N 3-(3,4-dichlorophenyl)-3-fluoropyrrolidine Chemical compound C=1C=C(Cl)C(Cl)=CC=1C1(F)CCNC1 XYUXXRTVBNMNBR-UHFFFAOYSA-N 0.000 description 1
• VTDDGZREKRAICG-UHFFFAOYSA-N 3-(3,4-dichlorophenyl)pyrrolidin-3-ol Chemical compound C=1C=C(Cl)C(Cl)=CC=1C1(O)CCNC1 VTDDGZREKRAICG-UHFFFAOYSA-N 0.000 description 1
• FZJXWTGTEDTPQU-UHFFFAOYSA-N 3-(3,4-difluorophenyl)-1-(2-methoxyethyl)pyrrolidin-3-ol Chemical compound C1N(CCOC)CCC1(O)C1=CC=C(F)C(F)=C1 FZJXWTGTEDTPQU-UHFFFAOYSA-N 0.000 description 1
• IMGABWQCVBLMMK-UHFFFAOYSA-N 3-(3,4-difluorophenyl)-1-(2-methylpropyl)pyrrolidin-3-ol Chemical compound C1N(CC(C)C)CCC1(O)C1=CC=C(F)C(F)=C1 IMGABWQCVBLMMK-UHFFFAOYSA-N 0.000 description 1
• PGCFUSUPZOPLNH-UHFFFAOYSA-N 3-(3,4-difluorophenyl)-3-fluoro-1-hydroxypyrrolidine Chemical compound C1N(O)CCC1(F)C1=CC=C(F)C(F)=C1 PGCFUSUPZOPLNH-UHFFFAOYSA-N 0.000 description 1
• TZODIYKCGSDCMR-UHFFFAOYSA-N 3-(3,4-difluorophenyl)-3-fluoro-1-methyl-1-oxidopyrrolidin-1-ium Chemical compound C1[N+](C)([O-])CCC1(F)C1=CC=C(F)C(F)=C1 TZODIYKCGSDCMR-UHFFFAOYSA-N 0.000 description 1
• QTMKEIDXWIIOPS-UHFFFAOYSA-N 3-(3,4-difluorophenyl)-3-fluoro-1-methylpyrrolidine Chemical compound C1N(C)CCC1(F)C1=CC=C(F)C(F)=C1 QTMKEIDXWIIOPS-UHFFFAOYSA-N 0.000 description 1
• FZBJSEJBSDDHFF-UHFFFAOYSA-N 3-(3,4-difluorophenyl)-3-fluoropyrrolidine Chemical compound C1=C(F)C(F)=CC=C1C1(F)CNCC1 FZBJSEJBSDDHFF-UHFFFAOYSA-N 0.000 description 1
• KQKGPWLLGCPEMH-UHFFFAOYSA-N 3-(3,5-dichlorophenyl)-1-(2-methoxyethyl)pyrrolidin-3-ol Chemical compound C1N(CCOC)CCC1(O)C1=CC(Cl)=CC(Cl)=C1 KQKGPWLLGCPEMH-UHFFFAOYSA-N 0.000 description 1
• VFDNOSLVLMYJNE-UHFFFAOYSA-N 3-(3,5-dichlorophenyl)-1-(2-methylpropyl)pyrrolidin-3-ol Chemical compound C1N(CC(C)C)CCC1(O)C1=CC(Cl)=CC(Cl)=C1 VFDNOSLVLMYJNE-UHFFFAOYSA-N 0.000 description 1
• OFUHBWDSHHZWAI-UHFFFAOYSA-N 3-(3,5-dichlorophenyl)-1-methylpyrrolidin-3-ol Chemical compound C1N(C)CCC1(O)C1=CC(Cl)=CC(Cl)=C1 OFUHBWDSHHZWAI-UHFFFAOYSA-N 0.000 description 1
• VKYUMMSVQBNZDR-UHFFFAOYSA-N 3-(3,5-dichlorophenyl)-1-propylpyrrolidin-3-ol Chemical compound C1N(CCC)CCC1(O)C1=CC(Cl)=CC(Cl)=C1 VKYUMMSVQBNZDR-UHFFFAOYSA-N 0.000 description 1
• IUXPMBHOOAIBGT-UHFFFAOYSA-N 3-(3,5-dichlorophenyl)-3-fluoro-1-hydroxypyrrolidine Chemical compound C1N(O)CCC1(F)C1=CC(Cl)=CC(Cl)=C1 IUXPMBHOOAIBGT-UHFFFAOYSA-N 0.000 description 1
• HYANLJQVEOCTEA-UHFFFAOYSA-N 3-(3,5-dichlorophenyl)-3-fluoro-1-methyl-1-oxidopyrrolidin-1-ium Chemical compound C1[N+](C)([O-])CCC1(F)C1=CC(Cl)=CC(Cl)=C1 HYANLJQVEOCTEA-UHFFFAOYSA-N 0.000 description 1
• FRGZYCPLKZLXIK-UHFFFAOYSA-N 3-(3,5-dichlorophenyl)-3-fluoro-1-methylpyrrolidine Chemical compound C1N(C)CCC1(F)C1=CC(Cl)=CC(Cl)=C1 FRGZYCPLKZLXIK-UHFFFAOYSA-N 0.000 description 1
• XNZJKTYMJYFUEU-UHFFFAOYSA-N 3-(3,5-difluorophenyl)-3-fluoro-1-hydroxypyrrolidine Chemical compound C1N(O)CCC1(F)C1=CC(F)=CC(F)=C1 XNZJKTYMJYFUEU-UHFFFAOYSA-N 0.000 description 1
• VVEKQZFDSLBZIX-UHFFFAOYSA-N 3-(3,5-difluorophenyl)-3-fluoro-1-methyl-1-oxidopyrrolidin-1-ium Chemical compound C1[N+](C)([O-])CCC1(F)C1=CC(F)=CC(F)=C1 VVEKQZFDSLBZIX-UHFFFAOYSA-N 0.000 description 1
• TYXMRTJGLYJEPM-UHFFFAOYSA-N 3-(3-chloro-2-fluorophenyl)-1-(2-methoxyethyl)pyrrolidin-3-ol Chemical compound C1N(CCOC)CCC1(O)C1=CC=CC(Cl)=C1F TYXMRTJGLYJEPM-UHFFFAOYSA-N 0.000 description 1
• OKZBOOZDEKIBAC-UHFFFAOYSA-N 3-(3-chloro-2-fluorophenyl)-1-(2-methylpropyl)pyrrolidin-3-ol Chemical compound C1N(CC(C)C)CCC1(O)C1=CC=CC(Cl)=C1F OKZBOOZDEKIBAC-UHFFFAOYSA-N 0.000 description 1
• PUGNAFPLAPAJLQ-UHFFFAOYSA-N 3-(3-chloro-2-fluorophenyl)-3-fluoro-1-methyl-1-oxidopyrrolidin-1-ium Chemical compound C1[N+](C)([O-])CCC1(F)C1=CC=CC(Cl)=C1F PUGNAFPLAPAJLQ-UHFFFAOYSA-N 0.000 description 1
• JLWWCOXZAZVVJX-UHFFFAOYSA-N 3-(3-chloro-2-fluorophenyl)-3-fluoro-1-methylpyrrolidine Chemical compound C1N(C)CCC1(F)C1=CC=CC(Cl)=C1F JLWWCOXZAZVVJX-UHFFFAOYSA-N 0.000 description 1
• LZMYCYCJXBPKBB-UHFFFAOYSA-N 3-(3-chloro-2-fluorophenyl)-3-fluoropyrrolidine Chemical compound FC1=C(Cl)C=CC=C1C1(F)CNCC1 LZMYCYCJXBPKBB-UHFFFAOYSA-N 0.000 description 1
• WYRPIIURWVTMDH-UHFFFAOYSA-N 3-(3-chloro-4-fluorophenyl)-1-(2-methoxyethyl)pyrrolidin-3-ol Chemical compound C1N(CCOC)CCC1(O)C1=CC=C(F)C(Cl)=C1 WYRPIIURWVTMDH-UHFFFAOYSA-N 0.000 description 1
• GUZIFNQSFAKLNT-UHFFFAOYSA-N 3-(3-chloro-4-fluorophenyl)-1-(2-methylpropyl)pyrrolidin-3-ol Chemical compound C1N(CC(C)C)CCC1(O)C1=CC=C(F)C(Cl)=C1 GUZIFNQSFAKLNT-UHFFFAOYSA-N 0.000 description 1
• VSTURXVDWDYGCP-UHFFFAOYSA-N 3-(3-chloro-4-fluorophenyl)-1-methylpyrrolidin-3-ol Chemical compound C1N(C)CCC1(O)C1=CC=C(F)C(Cl)=C1 VSTURXVDWDYGCP-UHFFFAOYSA-N 0.000 description 1
• QYDFJJVJVOJGIG-UHFFFAOYSA-N 3-(3-chloro-4-fluorophenyl)-3-fluoro-1-hydroxypyrrolidine Chemical compound C1N(O)CCC1(F)C1=CC=C(F)C(Cl)=C1 QYDFJJVJVOJGIG-UHFFFAOYSA-N 0.000 description 1
• OODZBWWYGHOLFR-UHFFFAOYSA-N 3-(3-chloro-4-fluorophenyl)-3-fluoro-1-methyl-1-oxidopyrrolidin-1-ium Chemical compound C1[N+](C)([O-])CCC1(F)C1=CC=C(F)C(Cl)=C1 OODZBWWYGHOLFR-UHFFFAOYSA-N 0.000 description 1
• QDXDPAXTOJIGDT-UHFFFAOYSA-N 3-(3-chloro-4-fluorophenyl)-3-fluoro-1-methylpyrrolidine Chemical compound C1N(C)CCC1(F)C1=CC=C(F)C(Cl)=C1 QDXDPAXTOJIGDT-UHFFFAOYSA-N 0.000 description 1
• RDYXRHQTWVWTOL-UHFFFAOYSA-N 3-(3-chloro-4-fluorophenyl)-3-fluoropyrrolidine Chemical compound C1=C(Cl)C(F)=CC=C1C1(F)CNCC1 RDYXRHQTWVWTOL-UHFFFAOYSA-N 0.000 description 1
• RDCHDIISDXQNHE-UHFFFAOYSA-N 3-(3-chloro-5-fluorophenyl)-1-(2-methoxyethyl)pyrrolidin-3-ol Chemical compound C1N(CCOC)CCC1(O)C1=CC(F)=CC(Cl)=C1 RDCHDIISDXQNHE-UHFFFAOYSA-N 0.000 description 1
• PSZTTZFWQQNPLZ-UHFFFAOYSA-N 3-(3-chloro-5-fluorophenyl)-1-(2-methylpropyl)pyrrolidin-3-ol Chemical compound C1N(CC(C)C)CCC1(O)C1=CC(F)=CC(Cl)=C1 PSZTTZFWQQNPLZ-UHFFFAOYSA-N 0.000 description 1
• FWAUUOWWCZPBEW-UHFFFAOYSA-N 3-(3-chloro-5-fluorophenyl)-1-ethyl-1-oxidopyrrolidin-1-ium-3-ol Chemical compound C1[N+](CC)([O-])CCC1(O)C1=CC(F)=CC(Cl)=C1 FWAUUOWWCZPBEW-UHFFFAOYSA-N 0.000 description 1
• VMZBPFCRNAJBGR-UHFFFAOYSA-N 3-(3-chloro-5-fluorophenyl)-1-ethyl-1-oxidopyrrolidin-1-ium-3-ol 3-(3-chloro-5-fluorophenyl)-1-ethylpyrrolidin-3-ol Chemical compound ClC=1C=C(C=C(C1)F)C1(CN(CC1)CC)O.ClC=1C=C(C=C(C1)F)C1(C[N+](CC1)(CC)[O-])O VMZBPFCRNAJBGR-UHFFFAOYSA-N 0.000 description 1
• GJQODOVPSYFFON-UHFFFAOYSA-N 3-(3-chloro-5-fluorophenyl)-3-fluoro-1-methyl-1-oxidopyrrolidin-1-ium Chemical compound C1[N+](C)([O-])CCC1(F)C1=CC(F)=CC(Cl)=C1 GJQODOVPSYFFON-UHFFFAOYSA-N 0.000 description 1
• HLPYBHXYFHAACL-UHFFFAOYSA-N 3-(3-chloro-5-fluorophenyl)-3-fluoro-1-methylpyrrolidine Chemical compound C1N(C)CCC1(F)C1=CC(F)=CC(Cl)=C1 HLPYBHXYFHAACL-UHFFFAOYSA-N 0.000 description 1
• XNVNQPBGCDCEIF-UHFFFAOYSA-N 3-(3-chloro-5-fluorophenyl)-3-fluoropyrrole Chemical compound ClC=1C=C(C=C(C1)F)C1(C=NC=C1)F XNVNQPBGCDCEIF-UHFFFAOYSA-N 0.000 description 1
• YATCDSPASHWBKD-UHFFFAOYSA-N 3-(3-chloro-5-fluorophenyl)-3-fluoropyrrolidine Chemical compound FC1=CC(Cl)=CC(C2(F)CNCC2)=C1 YATCDSPASHWBKD-UHFFFAOYSA-N 0.000 description 1
• NHCSUWRUBGQGJC-UHFFFAOYSA-N 3-(4-chloro-2-fluorophenyl)-1-(2-methoxyethyl)pyrrolidin-3-ol Chemical compound C1N(CCOC)CCC1(O)C1=CC=C(Cl)C=C1F NHCSUWRUBGQGJC-UHFFFAOYSA-N 0.000 description 1
• TYVBHYMCBWGORW-UHFFFAOYSA-N 3-(4-chloro-2-fluorophenyl)-1-(2-methylpropyl)pyrrolidin-3-ol Chemical compound C1N(CC(C)C)CCC1(O)C1=CC=C(Cl)C=C1F TYVBHYMCBWGORW-UHFFFAOYSA-N 0.000 description 1
• XPBUVLPXEPGDFZ-UHFFFAOYSA-N 3-(4-chloro-2-fluorophenyl)-1-ethylpyrrolidin-3-ol Chemical compound C1N(CC)CCC1(O)C1=CC=C(Cl)C=C1F XPBUVLPXEPGDFZ-UHFFFAOYSA-N 0.000 description 1
• UMYKUYZRICWKBF-UHFFFAOYSA-N 3-(4-chloro-2-fluorophenyl)-1-methylpyrrolidin-3-ol Chemical compound C1N(C)CCC1(O)C1=CC=C(Cl)C=C1F UMYKUYZRICWKBF-UHFFFAOYSA-N 0.000 description 1
• SCBPYVDWXXNTAW-UHFFFAOYSA-N 3-(4-chloro-2-fluorophenyl)-1-propylpyrrolidin-3-ol Chemical compound C1N(CCC)CCC1(O)C1=CC=C(Cl)C=C1F SCBPYVDWXXNTAW-UHFFFAOYSA-N 0.000 description 1
• UJQKEZWTLUYRRE-UHFFFAOYSA-N 3-(4-chloro-2-fluorophenyl)-3-fluoro-1-methyl-1-oxidopyrrolidin-1-ium Chemical compound C1[N+](C)([O-])CCC1(F)C1=CC=C(Cl)C=C1F UJQKEZWTLUYRRE-UHFFFAOYSA-N 0.000 description 1
• HAZORJKKZAUDCZ-UHFFFAOYSA-N 3-(4-chloro-2-fluorophenyl)-3-fluoro-1-methylpyrrolidine Chemical compound C1N(C)CCC1(F)C1=CC=C(Cl)C=C1F HAZORJKKZAUDCZ-UHFFFAOYSA-N 0.000 description 1
• HKIHDSHTUQOAED-UHFFFAOYSA-N 3-(4-chloro-2-fluorophenyl)-3-fluoropyrrolidine Chemical compound FC1=CC(Cl)=CC=C1C1(F)CNCC1 HKIHDSHTUQOAED-UHFFFAOYSA-N 0.000 description 1
• NQHHGSZVYXRBBL-UHFFFAOYSA-N 3-(4-chloro-3-fluorophenyl)-1-(2-methoxyethyl)pyrrolidin-3-ol Chemical compound C1N(CCOC)CCC1(O)C1=CC=C(Cl)C(F)=C1 NQHHGSZVYXRBBL-UHFFFAOYSA-N 0.000 description 1
• QSECLHCPBMEDQQ-UHFFFAOYSA-N 3-(4-chloro-3-fluorophenyl)-1-(2-methylpropyl)pyrrolidin-3-ol Chemical compound C1N(CC(C)C)CCC1(O)C1=CC=C(Cl)C(F)=C1 QSECLHCPBMEDQQ-UHFFFAOYSA-N 0.000 description 1
• DBKBBBVXCCDYDH-UHFFFAOYSA-N 3-(4-chloro-3-fluorophenyl)-1-ethylpyrrolidin-3-ol Chemical compound C1N(CC)CCC1(O)C1=CC=C(Cl)C(F)=C1 DBKBBBVXCCDYDH-UHFFFAOYSA-N 0.000 description 1
• QOBNEQSXKKCGAZ-UHFFFAOYSA-N 3-(4-chloro-3-fluorophenyl)-1-methylpyrrolidin-3-ol Chemical compound C1N(C)CCC1(O)C1=CC=C(Cl)C(F)=C1 QOBNEQSXKKCGAZ-UHFFFAOYSA-N 0.000 description 1
• DLPDYKYKTBSZRL-UHFFFAOYSA-N 3-(4-chloro-3-fluorophenyl)-1-propylpyrrolidin-3-ol Chemical compound C1N(CCC)CCC1(O)C1=CC=C(Cl)C(F)=C1 DLPDYKYKTBSZRL-UHFFFAOYSA-N 0.000 description 1
• CADBAUKYIUWENY-UHFFFAOYSA-N 3-(4-chloro-3-fluorophenyl)-3-fluoro-1-methyl-1-oxidopyrrolidin-1-ium Chemical compound C1[N+](C)([O-])CCC1(F)C1=CC=C(Cl)C(F)=C1 CADBAUKYIUWENY-UHFFFAOYSA-N 0.000 description 1
• MDTFWSXLUVNOQW-UHFFFAOYSA-N 3-(4-chloro-3-fluorophenyl)-3-fluoro-1-methylpyrrolidine Chemical compound C1N(C)CCC1(F)C1=CC=C(Cl)C(F)=C1 MDTFWSXLUVNOQW-UHFFFAOYSA-N 0.000 description 1
• JZLPONDYCZRJSS-UHFFFAOYSA-N 3-(4-chloro-3-fluorophenyl)-3-fluoropyrrolidine Chemical compound C1=C(Cl)C(F)=CC(C2(F)CNCC2)=C1 JZLPONDYCZRJSS-UHFFFAOYSA-N 0.000 description 1
• MGGZDDQAOZEEDU-UHFFFAOYSA-N 3-(4-chlorophenyl)pyrrolidine Chemical compound C1=CC(Cl)=CC=C1C1CNCC1 MGGZDDQAOZEEDU-UHFFFAOYSA-N 0.000 description 1
• NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 1
• NZYBILDYPCVNMU-UHFFFAOYSA-N 3-phenylpiperidine Chemical class C1CCNCC1C1=CC=CC=C1 NZYBILDYPCVNMU-UHFFFAOYSA-N 0.000 description 1
• BETHXCLHMRGYBW-UHFFFAOYSA-N 4-[3-(4-chlorophenyl)-3-hydroxypyrrolidin-1-yl]-1-(4-fluorophenyl)butan-1-one Chemical compound C1C(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 BETHXCLHMRGYBW-UHFFFAOYSA-N 0.000 description 1
• CFPZDVAZISWERM-UHFFFAOYSA-N 4-bromo-1,2-dichlorobenzene Chemical compound ClC1=CC=C(Br)C=C1Cl CFPZDVAZISWERM-UHFFFAOYSA-N 0.000 description 1
• CJTIWGBQCVYTQE-UHFFFAOYSA-N 4-bromo-2-chloro-1-fluorobenzene Chemical compound FC1=CC=C(Br)C=C1Cl CJTIWGBQCVYTQE-UHFFFAOYSA-N 0.000 description 1
• 102000040125 5-hydroxytryptamine receptor family Human genes 0.000 description 1
• 108091032151 5-hydroxytryptamine receptor family Proteins 0.000 description 1
• 108060003345 Adrenergic Receptor Proteins 0.000 description 1
• 102000017910 Adrenergic receptor Human genes 0.000 description 1
• QNAYBMKLOCPYGJ-UHFFFAOYSA-N Alanine Chemical compound CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 1
• 229940122361 Bisphosphonate Drugs 0.000 description 1
• 101100180402 Caenorhabditis elegans jun-1 gene Proteins 0.000 description 1
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
• OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
• 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
• 229940122444 Chemokine receptor antagonist Drugs 0.000 description 1
• 241000819038 Chichester Species 0.000 description 1
• KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
• 206010011168 Cortical dysfunction Diseases 0.000 description 1
• FMGYKKMPNATWHP-UHFFFAOYSA-N Cyperquat Chemical compound C1=C[N+](C)=CC=C1C1=CC=CC=C1 FMGYKKMPNATWHP-UHFFFAOYSA-N 0.000 description 1
• ZGUNAGUHMKGQNY-SSDOTTSWSA-N D-alpha-phenylglycine Chemical compound OC(=O)[C@H](N)C1=CC=CC=C1 ZGUNAGUHMKGQNY-SSDOTTSWSA-N 0.000 description 1
• YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 description 1
• FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
• 239000004338 Dichlorodifluoromethane Substances 0.000 description 1
• 229940127333 Dopamine D2 Antagonists Drugs 0.000 description 1
• 102000015554 Dopamine receptor Human genes 0.000 description 1
• 108050004812 Dopamine receptor Proteins 0.000 description 1
• 229940121891 Dopamine receptor antagonist Drugs 0.000 description 1
• 206010013710 Drug interaction Diseases 0.000 description 1
• 244000165918 Eucalyptus papuana Species 0.000 description 1
• BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 1
• 241000577872 Fusarium striatum Species 0.000 description 1
• AEMRFAOFKBGASW-UHFFFAOYSA-M Glycolate Chemical compound OCC([O-])=O AEMRFAOFKBGASW-UHFFFAOYSA-M 0.000 description 1
• 229920000084 Gum arabic Polymers 0.000 description 1
• CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
• PIWKPBJCKXDKJR-UHFFFAOYSA-N Isoflurane Chemical compound FC(F)OC(Cl)C(F)(F)F PIWKPBJCKXDKJR-UHFFFAOYSA-N 0.000 description 1
• YQEZLKZALYSWHR-UHFFFAOYSA-N Ketamine Chemical compound C=1C=CC=C(Cl)C=1C1(NC)CCCCC1=O YQEZLKZALYSWHR-UHFFFAOYSA-N 0.000 description 1
• WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 1
• ZGUNAGUHMKGQNY-ZETCQYMHSA-N L-alpha-phenylglycine zwitterion Chemical compound OC(=O)[C@@H](N)C1=CC=CC=C1 ZGUNAGUHMKGQNY-ZETCQYMHSA-N 0.000 description 1
• COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
• WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
• OFOBLEOULBTSOW-UHFFFAOYSA-L Malonate Chemical compound [O-]C(=O)CC([O-])=O OFOBLEOULBTSOW-UHFFFAOYSA-L 0.000 description 1
• AFVFQIVMOAPDHO-UHFFFAOYSA-M Methanesulfonate Chemical compound CS([O-])(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-M 0.000 description 1
• DUGOZIWVEXMGBE-UHFFFAOYSA-N Methylphenidate Chemical compound C=1C=CC=CC=1C(C(=O)OC)C1CCCCN1 DUGOZIWVEXMGBE-UHFFFAOYSA-N 0.000 description 1
• 101710151805 Mitochondrial intermediate peptidase 1 Proteins 0.000 description 1
• 101100219997 Mus musculus Ccr1 gene Proteins 0.000 description 1
• 102000004868 N-Methyl-D-Aspartate Receptors Human genes 0.000 description 1
• 108090001041 N-Methyl-D-Aspartate Receptors Proteins 0.000 description 1
• LVDRREOUMKACNJ-BKMJKUGQSA-N N-[(2R,3S)-2-(4-chlorophenyl)-1-(1,4-dimethyl-2-oxoquinolin-7-yl)-6-oxopiperidin-3-yl]-2-methylpropane-1-sulfonamide Chemical compound CC(C)CS(=O)(=O)N[C@H]1CCC(=O)N([C@@H]1c1ccc(Cl)cc1)c1ccc2c(C)cc(=O)n(C)c2c1 LVDRREOUMKACNJ-BKMJKUGQSA-N 0.000 description 1
• 229910002651 NO3 Inorganic materials 0.000 description 1
• 206010060860 Neurological symptom Diseases 0.000 description 1
• NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
• YNYAYWLBAHXHLL-UHFFFAOYSA-N Normetanephrine Chemical compound COC1=CC(C(O)CN)=CC=C1O YNYAYWLBAHXHLL-UHFFFAOYSA-N 0.000 description 1
• YNYAYWLBAHXHLL-MRVPVSSYSA-N Normetanephrine Natural products COC1=CC([C@H](O)CN)=CC=C1O YNYAYWLBAHXHLL-MRVPVSSYSA-N 0.000 description 1
• 229910019142 PO4 Inorganic materials 0.000 description 1
• 239000005662 Paraffin oil Substances 0.000 description 1
• 102000012338 Poly(ADP-ribose) Polymerases Human genes 0.000 description 1
• 108010061844 Poly(ADP-ribose) Polymerases Proteins 0.000 description 1
• 229920000776 Poly(Adenosine diphosphate-ribose) polymerase Polymers 0.000 description 1
• 206010062519 Poor quality sleep Diseases 0.000 description 1
• ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
• 241000288906 Primates Species 0.000 description 1
• XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
• 206010037180 Psychiatric symptoms Diseases 0.000 description 1
• 241000283984 Rodentia Species 0.000 description 1
• 241000610375 Sparisoma viride Species 0.000 description 1
• QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
• ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
• 208000016620 Tourette disease Diseases 0.000 description 1
• HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 1
• YZCKVEUIGOORGS-NJFSPNSNSA-N Tritium Chemical compound [3H] YZCKVEUIGOORGS-NJFSPNSNSA-N 0.000 description 1
• HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
• 239000000205 acacia gum Substances 0.000 description 1
• 235000010489 acacia gum Nutrition 0.000 description 1
• KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
• 239000004480 active ingredient Substances 0.000 description 1
• 230000001154 acute effect Effects 0.000 description 1
• 239000002671 adjuvant Substances 0.000 description 1
• 239000000556 agonist Substances 0.000 description 1
• 125000000217 alkyl group Chemical group 0.000 description 1
• 230000029936 alkylation Effects 0.000 description 1
• 238000005804 alkylation reaction Methods 0.000 description 1
• 239000004411 aluminium Substances 0.000 description 1
• XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
• 229910052782 aluminium Inorganic materials 0.000 description 1
• 150000001414 amino alcohols Chemical class 0.000 description 1
• 125000003277 amino group Chemical group 0.000 description 1
• 150000003863 ammonium salts Chemical class 0.000 description 1
• 210000004727 amygdala Anatomy 0.000 description 1
• 230000003444 anaesthetic effect Effects 0.000 description 1
• 230000000202 analgesic effect Effects 0.000 description 1
• 125000000129 anionic group Chemical group 0.000 description 1
• 229940125681 anticonvulsant agent Drugs 0.000 description 1
• 239000001961 anticonvulsive agent Substances 0.000 description 1
• 229940082988 antihypertensives serotonin antagonists Drugs 0.000 description 1
• 239000000164 antipsychotic agent Substances 0.000 description 1
• 239000003420 antiserotonin agent Substances 0.000 description 1
• 239000002249 anxiolytic agent Substances 0.000 description 1
• 230000000949 anxiolytic effect Effects 0.000 description 1
• 229940054021 anxiolytics diphenylmethane derivative Drugs 0.000 description 1
• 239000007864 aqueous solution Substances 0.000 description 1
• 230000037007 arousal Effects 0.000 description 1
• 229940072107 ascorbate Drugs 0.000 description 1
• 229960005070 ascorbic acid Drugs 0.000 description 1
• VHGCDTVCOLNTBX-QGZVFWFLSA-N atomoxetine Chemical compound O([C@H](CCNC)C=1C=CC=CC=1)C1=CC=CC=C1C VHGCDTVCOLNTBX-QGZVFWFLSA-N 0.000 description 1
• 229960002430 atomoxetine Drugs 0.000 description 1
• 230000003190 augmentative effect Effects 0.000 description 1
• 229940090047 auto-injector Drugs 0.000 description 1
• 230000003542 behavioural effect Effects 0.000 description 1
• SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 description 1
• WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
• 239000011230 binding agent Substances 0.000 description 1
• 230000004071 biological effect Effects 0.000 description 1
• 230000033228 biological regulation Effects 0.000 description 1
• 150000004663 bisphosphonates Chemical group 0.000 description 1
• 230000036772 blood pressure Effects 0.000 description 1
• 239000006172 buffering agent Substances 0.000 description 1
• 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
• 239000011575 calcium Substances 0.000 description 1
• 229910052791 calcium Inorganic materials 0.000 description 1
• CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
• 235000013539 calcium stearate Nutrition 0.000 description 1
• 239000008116 calcium stearate Substances 0.000 description 1
• 239000007963 capsule composition Substances 0.000 description 1
• 150000004657 carbamic acid derivatives Chemical class 0.000 description 1
• 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 1
• 150000001720 carbohydrates Chemical class 0.000 description 1
• 229960004424 carbon dioxide Drugs 0.000 description 1
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
• 239000001768 carboxy methyl cellulose Substances 0.000 description 1
• 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
• 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
• 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
• 239000000969 carrier Substances 0.000 description 1
• 210000004027 cell Anatomy 0.000 description 1
• 230000008859 change Effects 0.000 description 1
• 238000012512 characterization method Methods 0.000 description 1
• 239000003638 chemical reducing agent Substances 0.000 description 1
• 239000003795 chemical substances by application Substances 0.000 description 1
• 239000002559 chemokine receptor antagonist Substances 0.000 description 1
• 238000004296 chiral HPLC Methods 0.000 description 1
• FZFAMSAMCHXGEF-UHFFFAOYSA-N chloro formate Chemical compound ClOC=O FZFAMSAMCHXGEF-UHFFFAOYSA-N 0.000 description 1
• QOPVNWQGBQYBBP-UHFFFAOYSA-N chloroethyl chloroformate Chemical compound CC(Cl)OC(Cl)=O QOPVNWQGBQYBBP-UHFFFAOYSA-N 0.000 description 1
• 229960001231 choline Drugs 0.000 description 1
• OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
• 229940114081 cinnamate Drugs 0.000 description 1
• 208000035850 clinical syndrome Diseases 0.000 description 1
• 238000000576 coating method Methods 0.000 description 1
• 230000037410 cognitive enhancement Effects 0.000 description 1
• 230000007370 cognitive improvement Effects 0.000 description 1
• 239000003086 colorant Substances 0.000 description 1
• 238000004440 column chromatography Methods 0.000 description 1
• 229940125773 compound 10 Drugs 0.000 description 1
• 238000002591 computed tomography Methods 0.000 description 1
• 238000007796 conventional method Methods 0.000 description 1
• 238000001816 cooling Methods 0.000 description 1
• 229920001577 copolymer Polymers 0.000 description 1
• 230000002596 correlated effect Effects 0.000 description 1
• 239000013078 crystal Substances 0.000 description 1
• 230000003247 decreasing effect Effects 0.000 description 1
• 230000006735 deficit Effects 0.000 description 1
• 239000003479 dental cement Substances 0.000 description 1
• 230000001419 dependent effect Effects 0.000 description 1
• 238000013461 design Methods 0.000 description 1
• 229910052805 deuterium Inorganic materials 0.000 description 1
• 238000002405 diagnostic procedure Methods 0.000 description 1
• PXBRQCKWGAHEHS-UHFFFAOYSA-N dichlorodifluoromethane Chemical compound FC(F)(Cl)Cl PXBRQCKWGAHEHS-UHFFFAOYSA-N 0.000 description 1
• 235000019404 dichlorodifluoromethane Nutrition 0.000 description 1
• 229940042935 dichlorodifluoromethane Drugs 0.000 description 1
• 229940087091 dichlorotetrafluoroethane Drugs 0.000 description 1
• 230000009699 differential effect Effects 0.000 description 1
• 210000002249 digestive system Anatomy 0.000 description 1
• 150000004683 dihydrates Chemical class 0.000 description 1
• ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical class C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 1
• ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
• 238000006073 displacement reaction Methods 0.000 description 1
• 238000004821 distillation Methods 0.000 description 1
• 239000003136 dopamine receptor stimulating agent Substances 0.000 description 1
• 239000002552 dosage form Substances 0.000 description 1
• 229940112141 dry powder inhaler Drugs 0.000 description 1
• 125000006575 electron-withdrawing group Chemical group 0.000 description 1
• 230000008030 elimination Effects 0.000 description 1
• 238000003379 elimination reaction Methods 0.000 description 1
• 229950005627 embonate Drugs 0.000 description 1
• 229950011470 enantate Drugs 0.000 description 1
• 150000002148 esters Chemical class 0.000 description 1
• 239000000796 flavoring agent Substances 0.000 description 1
• 239000011888 foil Substances 0.000 description 1
• 235000013355 food flavoring agent Nutrition 0.000 description 1
• 238000001640 fractional crystallisation Methods 0.000 description 1
• 125000000524 functional group Chemical group 0.000 description 1
• 210000001222 gaba-ergic neuron Anatomy 0.000 description 1
• 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
• 239000007789 gas Substances 0.000 description 1
• 230000014509 gene expression Effects 0.000 description 1
• 230000002068 genetic effect Effects 0.000 description 1
• 210000002816 gill Anatomy 0.000 description 1
• 239000011521 glass Substances 0.000 description 1
• 229940049906 glutamate Drugs 0.000 description 1
• 230000000848 glutamatergic effect Effects 0.000 description 1
• 210000001362 glutamatergic neuron Anatomy 0.000 description 1
• 239000008187 granular material Substances 0.000 description 1
• 239000003395 histamine H3 receptor antagonist Substances 0.000 description 1
• 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
• 208000013403 hyperactivity Diseases 0.000 description 1
• 230000005032 impulse control Effects 0.000 description 1
• 239000003112 inhibitor Substances 0.000 description 1
• 229960002725 isoflurane Drugs 0.000 description 1
• ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 1
• 229960003299 ketamine Drugs 0.000 description 1
• 238000002372 labelling Methods 0.000 description 1
• 150000003951 lactams Chemical class 0.000 description 1
• 210000003715 limbic system Anatomy 0.000 description 1
• 229910052744 lithium Inorganic materials 0.000 description 1
• CETVQRFGPOGIQJ-UHFFFAOYSA-N lithium;hexane Chemical compound [Li+].CCCCC[CH2-] CETVQRFGPOGIQJ-UHFFFAOYSA-N 0.000 description 1
• 210000000627 locus coeruleus Anatomy 0.000 description 1
• 239000000314 lubricant Substances 0.000 description 1
• KDXKERNSBIXSRK-UHFFFAOYSA-O lysinium(1+) Chemical compound [NH3+]CCCCC([NH3+])C([O-])=O KDXKERNSBIXSRK-UHFFFAOYSA-O 0.000 description 1
• 238000002595 magnetic resonance imaging Methods 0.000 description 1
• VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
• IWYDHOAUDWTVEP-UHFFFAOYSA-M mandelate Chemical compound [O-]C(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-M 0.000 description 1
• 239000011159 matrix material Substances 0.000 description 1
• 238000005259 measurement Methods 0.000 description 1
• 230000001404 mediated effect Effects 0.000 description 1
• 238000002483 medication Methods 0.000 description 1
• 229960001344 methylphenidate Drugs 0.000 description 1
• 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 1
• 239000004005 microsphere Substances 0.000 description 1
• 230000004048 modification Effects 0.000 description 1
• 238000012986 modification Methods 0.000 description 1
• 230000000897 modulatory effect Effects 0.000 description 1
• 238000012544 monitoring process Methods 0.000 description 1
• 230000001730 monoaminergic effect Effects 0.000 description 1
• 150000004682 monohydrates Chemical class 0.000 description 1
• 230000036651 mood Effects 0.000 description 1
• 230000008450 motivation Effects 0.000 description 1
• LKPFBGKZCCBZDK-UHFFFAOYSA-N n-hydroxypiperidine Chemical class ON1CCCCC1 LKPFBGKZCCBZDK-UHFFFAOYSA-N 0.000 description 1
• KVBGVZZKJNLNJU-UHFFFAOYSA-N naphthalene-2-sulfonic acid Chemical compound C1=CC=CC2=CC(S(=O)(=O)O)=CC=C21 KVBGVZZKJNLNJU-UHFFFAOYSA-N 0.000 description 1
• 239000006199 nebulizer Substances 0.000 description 1
• 230000010004 neural pathway Effects 0.000 description 1
• 230000001722 neurochemical effect Effects 0.000 description 1
• 230000000626 neurodegenerative effect Effects 0.000 description 1
• 230000007171 neuropathology Effects 0.000 description 1
• 238000010855 neuropsychological testing Methods 0.000 description 1
• 230000007935 neutral effect Effects 0.000 description 1
• 125000004433 nitrogen atom Chemical group N* 0.000 description 1
• 230000000966 norepinephrine reuptake Effects 0.000 description 1
• QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
• 210000001010 olfactory tubercle Anatomy 0.000 description 1
• 235000006408 oxalic acid Nutrition 0.000 description 1
• AICOOMRHRUFYCM-ZRRPKQBOSA-N oxazine, 1 Chemical compound C([C@@H]1[C@H](C(C[C@]2(C)[C@@H]([C@H](C)N(C)C)[C@H](O)C[C@]21C)=O)CC1=CC2)C[C@H]1[C@@]1(C)[C@H]2N=C(C(C)C)OC1 AICOOMRHRUFYCM-ZRRPKQBOSA-N 0.000 description 1
• NXJCBFBQEVOTOW-UHFFFAOYSA-L palladium(2+);dihydroxide Chemical compound O[Pd]O NXJCBFBQEVOTOW-UHFFFAOYSA-L 0.000 description 1
• 229960003978 pamidronic acid Drugs 0.000 description 1
• 239000012188 paraffin wax Substances 0.000 description 1
• 230000036961 partial effect Effects 0.000 description 1
• 230000001717 pathogenic effect Effects 0.000 description 1
• 230000001575 pathological effect Effects 0.000 description 1
• VLTRZXGMWDSKGL-UHFFFAOYSA-M perchlorate Inorganic materials [O-]Cl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-M 0.000 description 1
• VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 1
• 150000004965 peroxy acids Chemical class 0.000 description 1
• 230000003285 pharmacodynamic effect Effects 0.000 description 1
• 238000011458 pharmacological treatment Methods 0.000 description 1
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
• 239000010452 phosphate Substances 0.000 description 1
• XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 1
• 238000000053 physical method Methods 0.000 description 1
• 229920002239 polyacrylonitrile Polymers 0.000 description 1
• 229920000642 polymer Polymers 0.000 description 1
• 229920001843 polymethylhydrosiloxane Polymers 0.000 description 1
• 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
• 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
• 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
• 230000001242 postsynaptic effect Effects 0.000 description 1
• 239000011591 potassium Substances 0.000 description 1
• 229910052700 potassium Inorganic materials 0.000 description 1
• 239000003755 preservative agent Substances 0.000 description 1
• 230000008569 process Effects 0.000 description 1
• 230000002035 prolonged effect Effects 0.000 description 1
• 239000003380 propellant Substances 0.000 description 1
• 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
• 125000006239 protecting group Chemical group 0.000 description 1
• 208000020016 psychiatric disease Diseases 0.000 description 1
• 239000003368 psychostimulant agent Substances 0.000 description 1
• 125000004076 pyridyl group Chemical group 0.000 description 1
• 239000011541 reaction mixture Substances 0.000 description 1
• 238000001953 recrystallisation Methods 0.000 description 1
• 230000004043 responsiveness Effects 0.000 description 1
• 238000004366 reverse phase liquid chromatography Methods 0.000 description 1
• 238000012552 review Methods 0.000 description 1
• CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
• YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
• 229960001860 salicylate Drugs 0.000 description 1
• 230000000698 schizophrenic effect Effects 0.000 description 1
• 150000003335 secondary amines Chemical class 0.000 description 1
• 230000009291 secondary effect Effects 0.000 description 1
• 230000035945 sensitivity Effects 0.000 description 1
• 210000002966 serum Anatomy 0.000 description 1
• 238000002603 single-photon emission computed tomography Methods 0.000 description 1
• 210000003625 skull Anatomy 0.000 description 1
• 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
• 235000017557 sodium bicarbonate Nutrition 0.000 description 1
• 239000012439 solid excipient Substances 0.000 description 1
• 229940075554 sorbate Drugs 0.000 description 1
• 241000894007 species Species 0.000 description 1
• 238000004611 spectroscopical analysis Methods 0.000 description 1
• 238000003756 stirring Methods 0.000 description 1
• 238000005728 strengthening Methods 0.000 description 1
• 125000001424 substituent group Chemical group 0.000 description 1
• KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
• IIACRCGMVDHOTQ-UHFFFAOYSA-N sulfamic acid Chemical class NS(O)(=O)=O IIACRCGMVDHOTQ-UHFFFAOYSA-N 0.000 description 1
• 229910021653 sulphate ion Inorganic materials 0.000 description 1
• 239000000829 suppository Substances 0.000 description 1
• 230000002459 sustained effect Effects 0.000 description 1
• 210000002820 sympathetic nervous system Anatomy 0.000 description 1
• 230000008293 synaptic mechanism Effects 0.000 description 1
• 235000020357 syrup Nutrition 0.000 description 1
• 239000006188 syrup Substances 0.000 description 1
• 230000009885 systemic effect Effects 0.000 description 1
• 239000007916 tablet composition Substances 0.000 description 1
• 239000000454 talc Substances 0.000 description 1
• 235000012222 talc Nutrition 0.000 description 1
• 229910052623 talc Inorganic materials 0.000 description 1
• 230000008685 targeting Effects 0.000 description 1
• 229940095064 tartrate Drugs 0.000 description 1
• 150000003892 tartrate salts Chemical class 0.000 description 1
• QGMBLJFZWOHDII-UHFFFAOYSA-N tert-butyl 3-(3-chloro-2-fluorophenyl)-3-hydroxypyrrolidine-1-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CCC1(O)C1=CC=CC(Cl)=C1F QGMBLJFZWOHDII-UHFFFAOYSA-N 0.000 description 1
• LEFRLGCGFPVLHQ-UHFFFAOYSA-N tert-butyl 3-(3-chloro-4-fluorophenyl)-3-hydroxypyrrolidine-1-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CCC1(O)C1=CC=C(F)C(Cl)=C1 LEFRLGCGFPVLHQ-UHFFFAOYSA-N 0.000 description 1
• 150000003512 tertiary amines Chemical class 0.000 description 1
• 150000004685 tetrahydrates Chemical class 0.000 description 1
• 150000003536 tetrazoles Chemical class 0.000 description 1
• 238000002560 therapeutic procedure Methods 0.000 description 1
• 239000002562 thickening agent Substances 0.000 description 1
• 239000004408 titanium dioxide Substances 0.000 description 1
• 235000010215 titanium dioxide Nutrition 0.000 description 1
• 230000002936 tranquilizing effect Effects 0.000 description 1
• WBYWAXJHAXSJNI-VOTSOKGWSA-M trans-cinnamate Chemical compound [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
• 230000009466 transformation Effects 0.000 description 1
• 238000000844 transformation Methods 0.000 description 1
• 125000005270 trialkylamine group Chemical group 0.000 description 1
• 150000003852 triazoles Chemical class 0.000 description 1
• CYRMSUTZVYGINF-UHFFFAOYSA-N trichlorofluoromethane Chemical compound FC(Cl)(Cl)Cl CYRMSUTZVYGINF-UHFFFAOYSA-N 0.000 description 1
• 229940029284 trichlorofluoromethane Drugs 0.000 description 1
• 150000004684 trihydrates Chemical class 0.000 description 1
• 229910052722 tritium Inorganic materials 0.000 description 1
• 230000007306 turnover Effects 0.000 description 1
• 239000003981 vehicle Substances 0.000 description 1
• PNVNVHUZROJLTJ-UHFFFAOYSA-N venlafaxine Chemical compound C1=CC(OC)=CC=C1C(CN(C)C)C1(O)CCCCC1 PNVNVHUZROJLTJ-UHFFFAOYSA-N 0.000 description 1
• 229960004688 venlafaxine Drugs 0.000 description 1
• 239000001993 wax Substances 0.000 description 1
• 230000003936 working memory Effects 0.000 description 1
• BPICBUSOMSTKRF-UHFFFAOYSA-N xylazine Chemical compound CC1=CC=CC(C)=C1NC1=NCCCS1 BPICBUSOMSTKRF-UHFFFAOYSA-N 0.000 description 1
• 229960001600 xylazine Drugs 0.000 description 1
• 239000011701 zinc Substances 0.000 description 1
• 229910052725 zinc Inorganic materials 0.000 description 1
• 229960004276 zoledronic acid Drugs 0.000 description 1
• 229940002005 zometa Drugs 0.000 description 1